Current Category: primary 
[1] "[2025-01-08 13:22:11]############################SOC-cardiac-serious-netmeta######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 125
   Unobserved stochastic nodes: 155
   Total graph size: 3490

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 13:22:11]Saved forest plot: 20250104-gemtc-forest-SOC-cardiac-serious-netmeta.pdf
[2025-01-08 13:22:11]Saved trace/density plot: 20250104-trace_density-SOC-cardiac-serious-netmeta.pdf
[2025-01-08 13:22:11]Saved diagnosis plot: 20250104-gelman.plot-SOC-cardiac-serious-netmeta.pdf
[1] "SOC-cardiac-serious-netmeta[2025-01-08 13:22:11]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Afatinib_HMGCRi                   1.09       1.23
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Erlotinib_chemotherapy        1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_COX2i                  1.15       1.39
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.47       2.11
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Rociletinib                      1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib_Erlotinib.Zorifertinib           1.00       1.00
d.Gefitinib.Almonertinib                     1.00       1.00
d.Gefitinib.Furmonertinib                    1.00       1.00
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_PARPi                  1.05       1.15
d.Gefitinib.Icotinib                         1.02       1.05
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Lazertinib                     1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
d.Osimertinib.Placebo                        1.00       1.00
sd.d                                         1.00       1.01

Multivariate psrf

1.36
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 125
   Unobserved stochastic nodes: 156
   Total graph size: 5426

[1] "SOC-cardiac-serious-netmeta[2025-01-08 13:22:11]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                            p.value  CrI                  
1  d.Afatinib.Chemotherapy               0.236975                      
2  -> direct                                      1.3 (-0.88, 3.7)     
3  -> indirect                                    -0.14 (-1.3, 0.97)   
4  -> network                                     0.14 (-0.83, 1.2)    
5  d.Afatinib.Erlotinib                  0.721500                      
6  -> direct                                      -0.0072 (-1.5, 1.6)  
7  -> indirect                                    0.32 (-0.90, 1.9)    
8  -> network                                     0.13 (-0.69, 1.1)    
9  d.Afatinib.Gefitinib                  0.717700                      
10 -> direct                                      -0.0080 (-1.8, 1.8)  
11 -> indirect                                    -0.36 (-1.8, 1.1)    
12 -> network                                     -0.22 (-1.3, 0.81)   
13 d.Afatinib.Placebo                    0.324325                      
14 -> direct                                      -0.93 (-2.9, 0.75)   
15 -> indirect                                    0.038 (-1.2, 1.4)    
16 -> network                                     -0.30 (-1.2, 0.68)   
17 d.Chemotherapy.Erlotinib              0.965050                      
18 -> direct                                      -0.044 (-1.0, 1.0)   
19 -> indirect                                    -0.010 (-1.6, 1.4)   
20 -> network                                     -0.0044 (-0.74, 0.77)
21 d.Chemotherapy.Erlotinib_chemotherapy 0.890500                      
22 -> direct                                      0.14 (-2.5, 2.5)     
23 -> indirect                                    0.34 (-1.5, 2.3)     
24 -> network                                     0.40 (-1.1, 2.0)     
25 d.Chemotherapy.Gefitinib              0.697600                      
26 -> direct                                      -0.14 (-1.9, 1.4)    
27 -> indirect                                    -0.52 (-2.0, 0.81)   
28 -> network                                     -0.34 (-1.4, 0.55)   
29 d.Chemotherapy.Osimertinib            0.438750                      
30 -> direct                                      1.4 (-0.84, 4.9)     
31 -> indirect                                    0.26 (-1.3, 1.9)     
32 -> network                                     0.54 (-0.70, 1.8)    
33 d.Dacomitinib.Erlotinib               0.297100                      
34 -> direct                                      0.26 (-1.2, 1.7)     
35 -> indirect                                    1.3 (-0.43, 3.1)     
36 -> network                                     0.58 (-0.39, 1.8)    
37 d.Dacomitinib.Gefitinib               0.974775                      
38 -> direct                                      0.21 (-3.7, 4.0)     
39 -> indirect                                    0.22 (-1.1, 1.7)     
40 -> network                                     0.24 (-1.1, 1.5)     
41 d.Dacomitinib.Placebo                 0.224275                      
42 -> direct                                      0.94 (-0.78, 2.8)    
43 -> indirect                                    -0.30 (-1.8, 1.0)    
44 -> network                                     0.16 (-0.96, 1.3)    
45 d.Erlotinib.Placebo                   0.796300                      
46 -> direct                                      -0.54 (-1.8, 0.56)   
47 -> indirect                                    -0.34 (-1.7, 0.77)   
48 -> network                                     -0.42 (-1.3, 0.30)   
49 d.Erlotinib.antiangio                     0.004025                      
50 -> direct                                      1.7 (0.69, 2.9)      
51 -> indirect                                    29. (4.4, 67.)       
52 -> network                                     2.2 (1.2, 3.8)       
53 d.Erlotinib_antiangio.antiangio               0.011475                      
54 -> direct                                      36. (3.7, 1.1e+02)   
55 -> indirect                                    1.6 (0.41, 3.2)      
56 -> network                                     1.9 (0.72, 3.7)      
57 d.Gefitinib.Lazertinib                0.562650                      
58 -> direct                                      0.44 (-1.8, 3.0)     
59 -> indirect                                    1.3 (-0.70, 3.9)     
60 -> network                                     0.89 (-0.54, 2.5)    
61 d.Gefitinib.Placebo                   0.881200                      
62 -> direct                                      0.013 (-1.8, 1.8)    
63 -> indirect                                    -0.15 (-1.3, 1.2)    
64 -> network                                     -0.080 (-1.0, 0.93)  
65 d.Gefitinib.antiangio                     0.012175                      
66 -> direct                                      19. (3.1, 50.)       
67 -> indirect                                    1.9 (0.59, 3.5)      
68 -> network                                     2.5 (1.4, 4.5)       
69 d.Lazertinib.Osimertinib              0.578825                      
70 -> direct                                      -0.21 (-1.8, 1.4)    
71 -> indirect                                    0.66 (-2.3, 3.7)     
72 -> network                                     -0.031 (-1.2, 1.3)   
73 d.Osimertinib.Placebo                 0.864025                      
74 -> direct                                      -0.92 (-2.7, 0.37)   
75 -> indirect                                    -1.2 (-3.5, 0.85)    
76 -> network                                     -0.95 (-2.2, 0.050)  
[2025-01-08 13:22:11]Saved diagnosis1 plot: 20250104-Consistency-SOC-cardiac-serious-netmeta.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 125
   Unobserved stochastic nodes: 125
   Total graph size: 2312

[1] "SOC-cardiac-serious-netmeta[2025-01-08 13:22:11]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair   i2.cons  incons.p
1                Afatinib            Afatinib_Cetuximab       NA        NA        NA
2                Afatinib          Afatinib_HMGCRi       NA        NA        NA
3                Afatinib             Chemotherapy 52.70439  5.453692 0.4839302
4                Afatinib                Erlotinib       NA  0.000000 0.9542173
5                Afatinib                Gefitinib       NA  0.000000 0.9034513
6                Afatinib                  Placebo       NA  2.139030 0.7530229
7            Almonertinib                Gefitinib       NA        NA        NA
8  Amivantamab_Lazertinib               Lazertinib       NA        NA        NA
9  Amivantamab_Lazertinib              Osimertinib       NA        NA        NA
10           Chemotherapy                Erlotinib 40.94922 19.236171 0.7231901
11           Chemotherapy   Erlotinib_chemotherapy       NA  0.000000 0.8497786
12           Chemotherapy                Gefitinib 58.98629 15.339642 0.9868055
13           Chemotherapy              Osimertinib       NA  0.000000 0.6827931
14            Dacomitinib                Erlotinib       NA  0.000000 0.8724353
15            Dacomitinib                Gefitinib       NA  0.000000 0.9186423
16            Dacomitinib                  Placebo       NA 15.212009 0.7014389
17                  DHFRi                Erlotinib       NA        NA        NA
18        Erlotinib_antiangio                    antiangio       NA  0.000000 0.2143843
19              Erlotinib   Erlotinib_chemotherapy  0.00000  0.000000        NA
20              Erlotinib          Erlotinib_COX2i       NA        NA        NA
21              Erlotinib          Erlotinib_HER3i       NA        NA        NA
22              Erlotinib           Erlotinib_IGF_1Ri 77.35062 64.770337        NA
23              Erlotinib           Erlotinib_METi 17.76501  0.000000        NA
24              Erlotinib           Erlotinib_MMPi       NA        NA        NA
25              Erlotinib          Erlotinib_antiangio 24.82605 25.282574        NA
26              Erlotinib                  Placebo  0.00000  0.000000 0.8578314
27              Erlotinib              Rociletinib       NA        NA        NA
28              Erlotinib                    antiangio 60.02806 57.524107 0.7858614
29          Furmonertinib                Gefitinib       NA        NA        NA
30    Gefitinib_Erlotinib              Osimertinib       NA        NA        NA
31    Gefitinib_Erlotinib             Zorifertinib       NA        NA        NA
32              Gefitinib   Gefitinib_chemotherapy       NA        NA        NA
33              Gefitinib          Gefitinib_PARPi       NA        NA        NA
34              Gefitinib                 Icotinib       NA        NA        NA
35              Gefitinib               Lazertinib       NA  0.000000 0.8657155
36              Gefitinib                  Placebo       NA  0.000000 0.9706715
37              Gefitinib                    antiangio       NA 39.451238 0.3481633
38             Lazertinib              Osimertinib       NA  0.000000 0.9348521
39            Osimertinib Osimertinib_chemotherapy       NA        NA        NA
40            Osimertinib        Osimertinib_antiangio 65.13394 64.268472        NA
41            Osimertinib                  Placebo 71.35916 10.573957 0.8558782

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 77.24468 23.17921
[2025-01-08 13:22:11]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-cardiac-serious-netmeta.pdf
[1] "[2025-01-08 13:41:11]############################SOC-cardiac-total-netmeta######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 143
   Unobserved stochastic nodes: 178
   Total graph size: 4184

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 13:41:11]Saved forest plot: 20250104-gemtc-forest-SOC-cardiac-total-netmeta.pdf
[2025-01-08 13:41:11]Saved trace/density plot: 20250104-trace_density-SOC-cardiac-total-netmeta.pdf
[2025-01-08 13:41:11]Saved diagnosis plot: 20250104-gelman.plot-SOC-cardiac-total-netmeta.pdf
[1] "SOC-cardiac-total-netmeta[2025-01-08 13:41:11]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Afatinib_HMGCRi                   1.00       1.00
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Erlotinib_chemotherapy        1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.00       1.00
d.Erlotinib.Erlotinib_COX2i                  1.05       1.12
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_HGFi                   1.11       1.29
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.00       1.00
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Rociletinib                      1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib_Erlotinib.Zorifertinib           1.00       1.00
d.Gefitinib.Almonertinib                     1.00       1.00
d.Gefitinib.Furmonertinib                    1.00       1.00
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_PARPi                  1.08       1.17
d.Gefitinib.Icotinib                         1.04       1.11
d.Gefitinib.Lazertinib                       1.00       1.00
d.Icotinib.Befotertinib                      1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Chemotherapy_antiangio             1.58       2.54
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_PD_L1i             1.03       1.08
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.43
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 143
   Unobserved stochastic nodes: 179
   Total graph size: 6790

[1] "SOC-cardiac-total-netmeta[2025-01-08 13:41:11]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                            p.value  CrI                 
1  d.Afatinib.Chemotherapy               0.326825                     
2  -> direct                                      1.1 (-0.79, 3.3)    
3  -> indirect                                    -0.034 (-0.98, 0.87)
4  -> network                                     0.16 (-0.67, 1.0)   
5  d.Afatinib.Erlotinib                  0.850175                     
6  -> direct                                      -0.0089 (-1.1, 1.1) 
7  -> indirect                                    0.14 (-0.85, 1.3)   
8  -> network                                     0.057 (-0.64, 0.88) 
9  d.Afatinib.Gefitinib                  0.729425                     
10 -> direct                                      -0.016 (-1.4, 1.5)  
11 -> indirect                                    -0.32 (-1.5, 0.80)  
12 -> network                                     -0.21 (-1.1, 0.69)  
13 d.Afatinib.Placebo                    0.242900                     
14 -> direct                                      -1.0 (-2.7, 0.38)   
15 -> indirect                                    -0.045 (-1.0, 0.93) 
16 -> network                                     -0.34 (-1.2, 0.46)  
17 d.Chemotherapy.Erlotinib              0.892900                     
18 -> direct                                      -0.14 (-0.89, 0.62) 
19 -> indirect                                    -0.061 (-1.3, 1.1)  
20 -> network                                     -0.11 (-0.70, 0.53) 
21 d.Chemotherapy.Erlotinib_chemotherapy 0.955300                     
22 -> direct                                      0.053 (-2.6, 2.5)   
23 -> indirect                                    0.10 (-1.2, 1.4)    
24 -> network                                     0.19 (-0.96, 1.3)   
25 d.Chemotherapy.Gefitinib              0.575450                     
26 -> direct                                      -0.13 (-1.5, 1.3)   
27 -> indirect                                    -0.59 (-1.7, 0.49)  
28 -> network                                     -0.37 (-1.3, 0.47)  
29 d.Chemotherapy.Osimertinib            0.554125                     
30 -> direct                                      1.0 (-0.40, 2.7)    
31 -> indirect                                    0.47 (-0.67, 1.6)   
32 -> network                                     0.66 (-0.24, 1.6)   
33 d.Dacomitinib.Erlotinib               0.379600                     
34 -> direct                                      0.42 (-0.61, 1.5)   
35 -> indirect                                    1.2 (-0.33, 2.9)    
36 -> network                                     0.61 (-0.19, 1.6)   
37 d.Dacomitinib.Gefitinib               0.719525                     
38 -> direct                                      -0.17 (-3.7, 3.4)   
39 -> indirect                                    0.42 (-0.71, 1.6)   
40 -> network                                     0.36 (-0.81, 1.5)   
41 d.Dacomitinib.Placebo                 0.247250                     
42 -> direct                                      0.95 (-0.60, 2.7)   
43 -> indirect                                    -0.13 (-1.4, 0.98)  
44 -> network                                     0.22 (-0.72, 1.2)   
45 d.Erlotinib.Placebo                   0.793825                     
46 -> direct                                      -0.51 (-1.5, 0.43)  
47 -> indirect                                    -0.33 (-1.3, 0.54)  
48 -> network                                     -0.40 (-1.1, 0.24)  
49 d.Erlotinib.antiangio                     0.010550                     
50 -> direct                                      1.8 (0.91, 3.0)     
51 -> indirect                                    18. (3.1, 53.)      
52 -> network                                     2.2 (1.3, 3.3)      
53 d.Erlotinib_antiangio.antiangio               0.646650                     
54 -> direct                                      2.4 (0.30, 5.7)     
55 -> indirect                                    1.8 (0.78, 3.1)     
56 -> network                                     2.0 (1.1, 3.2)      
57 d.Gefitinib.Lazertinib                0.544525                     
58 -> direct                                      0.55 (-1.5, 2.9)    
59 -> indirect                                    1.4 (-0.21, 3.1)    
60 -> network                                     1.1 (-0.24, 2.4)    
61 d.Gefitinib.Placebo                   0.796200                     
62 -> direct                                      -0.0019 (-1.5, 1.6) 
63 -> indirect                                    -0.22 (-1.3, 0.85)  
64 -> network                                     -0.13 (-1.0, 0.72)  
65 d.Gefitinib.antiangio                     0.004475                     
66 -> direct                                      16. (3.8, 73.)      
67 -> indirect                                    1.9 (0.68, 3.2)     
68 -> network                                     2.4 (1.3, 3.8)      
69 d.Lazertinib.Osimertinib              0.522825                     
70 -> direct                                      -0.20 (-1.4, 1.0)   
71 -> indirect                                    0.68 (-1.9, 3.1)    
72 -> network                                     -0.020 (-1.1, 1.1)  
73 d.Osimertinib.Placebo                 0.934950                     
74 -> direct                                      -1.2 (-2.3, -0.28)  
75 -> indirect                                    -1.2 (-2.9, 0.25)   
76 -> network                                     -1.2 (-2.0, -0.44)  
[2025-01-08 13:41:11]Saved diagnosis1 plot: 20250104-Consistency-SOC-cardiac-total-netmeta.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 143
   Unobserved stochastic nodes: 143
   Total graph size: 2646

[1] "SOC-cardiac-total-netmeta[2025-01-08 13:41:11]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair   i2.cons  incons.p
1                Afatinib            Afatinib_Cetuximab       NA        NA        NA
2                Afatinib          Afatinib_HMGCRi       NA        NA        NA
3                Afatinib             Chemotherapy 47.85568  8.272017 0.3009928
4                Afatinib                Erlotinib       NA  0.000000 0.9067135
5                Afatinib                Gefitinib       NA  0.000000 0.8070500
6                Afatinib                  Placebo       NA  7.396721 0.4493513
7            Almonertinib                Gefitinib       NA        NA        NA
8  Amivantamab_Lazertinib               Lazertinib       NA        NA        NA
9  Amivantamab_Lazertinib              Osimertinib       NA        NA        NA
10           Befotertinib                 Icotinib       NA        NA        NA
11     Chemotherapy_antiangio              Osimertinib       NA        NA        NA
12           Chemotherapy                Erlotinib 37.35744 21.935887 0.7538513
13           Chemotherapy   Erlotinib_chemotherapy       NA  0.000000 0.8951207
14           Chemotherapy                Gefitinib 46.80262 14.909348 0.7335409
15           Chemotherapy              Osimertinib       NA  0.000000 0.6409253
16            Dacomitinib                Erlotinib       NA  0.000000 0.7327065
17            Dacomitinib                Gefitinib       NA  0.000000 0.9047438
18            Dacomitinib                  Placebo       NA 18.259008 0.3708838
19                  DHFRi                Erlotinib       NA        NA        NA
20        Erlotinib_antiangio                    antiangio       NA  0.000000 0.6616362
21              Erlotinib     Erlotinib_Autophagyi       NA        NA        NA
22              Erlotinib   Erlotinib_chemotherapy  0.00000  0.000000        NA
23              Erlotinib          Erlotinib_COX2i       NA        NA        NA
24              Erlotinib          Erlotinib_HER3i       NA        NA        NA
25              Erlotinib           Erlotinib_HGFi       NA        NA        NA
26              Erlotinib           Erlotinib_IGF_1Ri 76.24144 72.234246        NA
27              Erlotinib           Erlotinib_METi  0.00000  0.000000        NA
28              Erlotinib           Erlotinib_MMPi       NA        NA        NA
29              Erlotinib          Erlotinib_antiangio 30.98834 30.592094        NA
30              Erlotinib                  Placebo  0.00000  0.000000 0.7615020
31              Erlotinib              Rociletinib       NA        NA        NA
32              Erlotinib                    antiangio 54.43718 52.885790 0.3552647
33          Furmonertinib                Gefitinib       NA        NA        NA
34    Gefitinib_Erlotinib              Osimertinib       NA        NA        NA
35    Gefitinib_Erlotinib             Zorifertinib       NA        NA        NA
36              Gefitinib   Gefitinib_chemotherapy  0.00000  0.000000        NA
37              Gefitinib          Gefitinib_PARPi       NA        NA        NA
38              Gefitinib                 Icotinib       NA        NA        NA
39              Gefitinib               Lazertinib       NA  0.000000 0.5766579
40              Gefitinib                  Placebo       NA  0.000000 0.8344855
41              Gefitinib                    antiangio       NA 75.988246 0.1283892
42             Lazertinib              Osimertinib       NA  0.000000 0.8094304
43            Osimertinib Osimertinib_chemotherapy 70.48890 64.615581        NA
44            Osimertinib       Osimertinib_PD_L1i       NA        NA        NA
45            Osimertinib        Osimertinib_antiangio 39.39464 39.390642        NA
46            Osimertinib                  Placebo 49.38591  0.000000 0.9344380

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 36.43373 21.89612
[2025-01-08 13:41:11]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-cardiac-total-netmeta.pdf
[1] "[2025-01-08 14:05:24]############################SOC-vascular-serious-netmeta######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 155
   Unobserved stochastic nodes: 183
   Total graph size: 3957

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 14:05:24]Saved forest plot: 20250104-gemtc-forest-SOC-vascular-serious-netmeta.pdf
[2025-01-08 14:05:24]Saved trace/density plot: 20250104-trace_density-SOC-vascular-serious-netmeta.pdf
[2025-01-08 14:05:24]Saved diagnosis plot: 20250104-gelman.plot-SOC-vascular-serious-netmeta.pdf
[1] "SOC-vascular-serious-netmeta[2025-01-08 14:05:24]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Erlotinib_chemotherapy        1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.02       1.06
d.Erlotinib.Erlotinib_ERi                    1.08       1.20
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_HGFi                   1.01       1.03
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.01       1.02
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Rociletinib                      1.01       1.02
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib.Almonertinib                     1.04       1.12
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_antiangio                  1.00       1.00
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.06
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 155
   Unobserved stochastic nodes: 184
   Total graph size: 5653

[1] "SOC-vascular-serious-netmeta[2025-01-08 14:05:24]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                            p.value  CrI               
1  d.Afatinib.Chemotherapy               0.660625                   
2  -> direct                                      0.42 (-1.6, 2.5)  
3  -> indirect                                    -0.14 (-1.7, 1.4) 
4  -> network                                     0.051 (-1.1, 1.3) 
5  d.Afatinib.Erlotinib                  0.779700                   
6  -> direct                                      -0.22 (-2.2, 1.8) 
7  -> indirect                                    -0.55 (-2.0, 0.97)
8  -> network                                     -0.43 (-1.5, 0.73)
9  d.Afatinib.Gefitinib                  0.943050                   
10 -> direct                                      -0.44 (-2.6, 1.6) 
11 -> indirect                                    -0.54 (-2.1, 1.1) 
12 -> network                                     -0.50 (-1.7, 0.75)
13 d.Afatinib.Placebo                    0.344750                   
14 -> direct                                      -1.6 (-4.2, 0.72) 
15 -> indirect                                    -0.28 (-1.7, 1.2) 
16 -> network                                     -0.62 (-1.9, 0.58)
17 d.Chemotherapy.Erlotinib              0.303375                   
18 -> direct                                      -0.20 (-1.3, 0.89)
19 -> indirect                                    -1.2 (-2.9, 0.41) 
20 -> network                                     -0.48 (-1.4, 0.38)
21 d.Chemotherapy.Erlotinib_chemotherapy 0.950550                   
22 -> direct                                      -0.91 (-4.8, 2.2) 
23 -> indirect                                    -0.79 (-2.9, 1.2) 
24 -> network                                     -0.71 (-2.5, 1.0) 
25 d.Chemotherapy.Gefitinib              0.334375                   
26 -> direct                                      -1.4 (-3.8, 0.60) 
27 -> indirect                                    -0.20 (-1.6, 1.2) 
28 -> network                                     -0.55 (-1.7, 0.54)
29 d.Chemotherapy.Osimertinib            0.972875                   
30 -> direct                                      -0.36 (-2.4, 1.7) 
31 -> indirect                                    -0.41 (-2.4, 1.6) 
32 -> network                                     -0.39 (-1.8, 0.98)
33 d.Dacomitinib.Erlotinib               0.911150                   
34 -> direct                                      0.23 (-1.4, 1.9)  
35 -> indirect                                    0.093 (-1.7, 1.9) 
36 -> network                                     0.15 (-0.98, 1.3) 
37 d.Dacomitinib.Gefitinib               0.911225                   
38 -> direct                                      0.17 (-2.0, 2.3)  
39 -> indirect                                    0.026 (-1.7, 1.7) 
40 -> network                                     0.086 (-1.2, 1.4) 
41 d.Dacomitinib.Placebo                 0.808100                   
42 -> direct                                      -0.25 (-2.4, 1.8) 
43 -> indirect                                    0.060 (-1.5, 1.6) 
44 -> network                                     -0.043 (-1.3, 1.2)
45 d.Erlotinib.Placebo                   0.083875                   
46 -> direct                                      0.52 (-0.72, 1.7) 
47 -> indirect                                    -1.1 (-2.5, 0.26) 
48 -> network                                     -0.20 (-1.2, 0.71)
49 d.Erlotinib.antiangio                     0.347575                   
50 -> direct                                      1.7 (0.34, 3.3)   
51 -> indirect                                    3.3 (0.36, 6.9)   
52 -> network                                     2.2 (1.0, 3.5)    
53 d.Erlotinib_antiangio.antiangio               0.071775                   
54 -> direct                                      2.1 (0.089, 4.3)  
55 -> indirect                                    -0.19 (-1.6, 1.3) 
56 -> network                                     0.82 (-0.41, 2.2) 
57 d.Gefitinib.Lazertinib                0.725675                   
58 -> direct                                      0.15 (-2.0, 2.3)  
59 -> indirect                                    0.73 (-1.9, 3.4)  
60 -> network                                     0.36 (-1.2, 2.0)  
61 d.Gefitinib.Placebo                   0.329525                   
62 -> direct                                      -0.88 (-3.0, 1.0) 
63 -> indirect                                    0.25 (-1.1, 1.7)  
64 -> network                                     -0.13 (-1.2, 0.97)
65 d.Gefitinib.antiangio                     0.513050                   
66 -> direct                                      3.0 (0.49, 6.8)   
67 -> indirect                                    2.0 (0.24, 3.9)   
68 -> network                                     2.3 (0.87, 3.8)   
69 d.Lazertinib.Osimertinib              0.723250                   
70 -> direct                                      -0.38 (-2.3, 1.6) 
71 -> indirect                                    0.19 (-2.5, 3.0)  
72 -> network                                     -0.20 (-1.7, 1.4) 
73 d.Osimertinib.Placebo                 0.786050                   
74 -> direct                                      -0.51 (-2.6, 1.5) 
75 -> indirect                                    -0.14 (-2.2, 1.8) 
76 -> network                                     -0.30 (-1.7, 1.1) 
[2025-01-08 14:05:24]Saved diagnosis1 plot: 20250104-Consistency-SOC-vascular-serious-netmeta.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 155
   Unobserved stochastic nodes: 155
   Total graph size: 2854

[1] "SOC-vascular-serious-netmeta[2025-01-08 14:05:24]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2   i2.pair    i2.cons   incons.p
1                Afatinib            Afatinib_Cetuximab        NA         NA         NA
2                Afatinib             Chemotherapy 64.671577 13.3859530 0.68125001
3                Afatinib                Erlotinib        NA  0.0000000 0.80693118
4                Afatinib                Gefitinib        NA  0.0000000 0.93898249
5                Afatinib                  Placebo        NA 28.3597406 0.42968356
6            Almonertinib                Gefitinib        NA         NA         NA
7  Amivantamab_Lazertinib               Lazertinib        NA         NA         NA
8  Amivantamab_Lazertinib              Osimertinib        NA         NA         NA
9            Chemotherapy                Erlotinib 58.526732 54.1669428 0.23557034
10           Chemotherapy   Erlotinib_chemotherapy        NA  0.0000000 0.85160048
11           Chemotherapy                Gefitinib 53.972808 27.5534312 0.38222503
12           Chemotherapy              Osimertinib        NA  0.0000000 0.97644414
13            Dacomitinib                Erlotinib  0.000000  0.0000000 0.92080046
14            Dacomitinib                Gefitinib        NA  0.0000000 0.92167699
15            Dacomitinib                  Placebo        NA  0.0000000 0.83359418
16                  DHFRi                Erlotinib        NA         NA         NA
17        Erlotinib_antiangio                    antiangio        NA 72.8544734 0.21114366
18              Erlotinib     Erlotinib_Autophagyi        NA         NA         NA
19              Erlotinib   Erlotinib_chemotherapy  0.000000  0.0000000         NA
20              Erlotinib            Erlotinib_ERi        NA         NA         NA
21              Erlotinib          Erlotinib_HER3i        NA         NA         NA
22              Erlotinib           Erlotinib_HGFi        NA         NA         NA
23              Erlotinib           Erlotinib_IGF_1Ri 59.731372 58.7669057         NA
24              Erlotinib           Erlotinib_METi  4.559514  4.4596268         NA
25              Erlotinib           Erlotinib_MMPi        NA         NA         NA
26              Erlotinib          Erlotinib_antiangio 74.070000 73.1406170         NA
27              Erlotinib                  Placebo  0.000000 47.7567488 0.15876260
28              Erlotinib              Rociletinib        NA         NA         NA
29              Erlotinib                    antiangio 30.465608 94.3564249 0.05186331
30    Gefitinib_Erlotinib              Osimertinib        NA         NA         NA
31              Gefitinib   Gefitinib_chemotherapy  0.000000  0.0000000         NA
32              Gefitinib          Gefitinib_antiangio 44.986722 43.9408155         NA
33              Gefitinib               Lazertinib        NA  0.0000000 0.76698888
34              Gefitinib                  Placebo 61.644384  0.9383055 0.40078085
35              Gefitinib                    antiangio        NA  0.0000000 0.54623579
36             Lazertinib              Osimertinib        NA  0.0000000 0.81967538
37            Osimertinib Osimertinib_chemotherapy 35.385201 35.1811962         NA
38            Osimertinib        Osimertinib_antiangio 48.295579 48.9319721         NA
39            Osimertinib                  Placebo  0.000000  0.0000000 0.79331067

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 63.01311 59.81239
[2025-01-08 14:05:24]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-vascular-serious-netmeta.pdf
[1] "[2025-01-08 14:30:40]############################SOC-vascular-total-netmeta######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 167
   Unobserved stochastic nodes: 198
   Total graph size: 4389

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 14:30:40]Saved forest plot: 20250104-gemtc-forest-SOC-vascular-total-netmeta.pdf
[2025-01-08 14:30:40]Saved trace/density plot: 20250104-trace_density-SOC-vascular-total-netmeta.pdf
[2025-01-08 14:30:40]Saved diagnosis plot: 20250104-gelman.plot-SOC-vascular-total-netmeta.pdf
[1] "SOC-vascular-total-netmeta[2025-01-08 14:30:40]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Erlotinib_chemotherapy        1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.00       1.00
d.Erlotinib.Erlotinib_COX2i                  1.04       1.11
d.Erlotinib.Erlotinib_ERi                    1.00       1.00
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_HGFi                   1.00       1.00
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.00       1.00
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Gefitinib_ERi                    1.00       1.00
d.Erlotinib.Rociletinib                      1.04       1.10
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib.Almonertinib                     1.00       1.00
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_antiangio                  1.00       1.00
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
d.Osimertinib.PD_L1i                         1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.04
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 167
   Unobserved stochastic nodes: 199
   Total graph size: 6450

[1] "SOC-vascular-total-netmeta[2025-01-08 14:30:40]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                            p.value  CrI                  
1  d.Afatinib.Chemotherapy               0.484825                      
2  -> direct                                      0.83 (-0.59, 2.3)    
3  -> indirect                                    0.18 (-1.0, 1.4)     
4  -> network                                     0.44 (-0.45, 1.4)    
5  d.Afatinib.Erlotinib                  0.992675                      
6  -> direct                                      -0.22 (-1.8, 1.4)    
7  -> indirect                                    -0.22 (-1.3, 0.92)   
8  -> network                                     -0.23 (-1.1, 0.69)   
9  d.Afatinib.Gefitinib                  0.774475                      
10 -> direct                                      -0.13 (-1.8, 1.6)    
11 -> indirect                                    -0.42 (-1.7, 0.75)   
12 -> network                                     -0.33 (-1.3, 0.63)   
13 d.Afatinib.Placebo                    0.224550                      
14 -> direct                                      -1.5 (-3.8, 0.41)    
15 -> indirect                                    -0.12 (-1.3, 1.0)    
16 -> network                                     -0.47 (-1.5, 0.51)   
17 d.Chemotherapy.Erlotinib              0.071775                      
18 -> direct                                      -0.22 (-1.1, 0.63)   
19 -> indirect                                    -1.5 (-2.8, -0.39)   
20 -> network                                     -0.67 (-1.4, -0.0057)
21 d.Chemotherapy.Erlotinib_chemotherapy 0.843650                      
22 -> direct                                      -0.88 (-4.7, 2.1)    
23 -> indirect                                    -0.56 (-2.2, 1.1)    
24 -> network                                     -0.54 (-2.0, 0.85)   
25 d.Chemotherapy.Gefitinib              0.104175                      
26 -> direct                                      -2.0 (-4.2, -0.34)   
27 -> indirect                                    -0.35 (-1.4, 0.68)   
28 -> network                                     -0.77 (-1.6, 0.045)  
29 d.Chemotherapy.Osimertinib            0.912475                      
30 -> direct                                      -0.67 (-2.2, 0.91)   
31 -> indirect                                    -0.56 (-2.1, 0.97)   
32 -> network                                     -0.61 (-1.7, 0.45)   
33 d.Dacomitinib.Erlotinib               0.953100                      
34 -> direct                                      0.20 (-1.2, 1.6)     
35 -> indirect                                    0.15 (-1.2, 1.5)     
36 -> network                                     0.16 (-0.75, 1.1)    
37 d.Dacomitinib.Gefitinib               0.871650                      
38 -> direct                                      0.14 (-1.4, 1.7)     
39 -> indirect                                    -0.015 (-1.4, 1.3)   
40 -> network                                     0.063 (-0.92, 1.1)   
41 d.Dacomitinib.Placebo                 0.816525                      
42 -> direct                                      -0.24 (-2.0, 1.5)    
43 -> indirect                                    0.00071 (-1.3, 1.2)  
44 -> network                                     -0.079 (-1.1, 0.92)  
45 d.Erlotinib.Gefitinib                 0.504250                      
46 -> direct                                      0.46 (-1.4, 2.4)     
47 -> indirect                                    -0.23 (-1.1, 0.63)   
48 -> network                                     -0.10 (-0.92, 0.67)  
49 d.Erlotinib.Placebo                   0.059925                      
50 -> direct                                      0.37 (-0.60, 1.4)    
51 -> indirect                                    -1.0 (-2.2, 0.060)   
52 -> network                                     -0.24 (-1.0, 0.48)   
53 d.Erlotinib.antiangio                     0.412425                      
54 -> direct                                      1.9 (0.83, 3.1)      
55 -> indirect                                    3.1 (0.56, 6.8)      
56 -> network                                     2.1 (1.2, 3.0)       
57 d.Erlotinib_antiangio.antiangio               0.713900                      
58 -> direct                                      0.70 (-0.98, 2.4)    
59 -> indirect                                    0.31 (-1.0, 1.7)     
60 -> network                                     0.51 (-0.46, 1.5)    
61 d.Gefitinib.Lazertinib                0.778350                      
62 -> direct                                      0.27 (-1.2, 1.8)     
63 -> indirect                                    0.62 (-1.4, 2.6)     
64 -> network                                     0.39 (-0.78, 1.6)    
65 d.Gefitinib.Placebo                   0.384700                      
66 -> direct                                      -0.77 (-2.6, 0.90)   
67 -> indirect                                    0.083 (-0.95, 1.1)   
68 -> network                                     -0.14 (-1.0, 0.72)   
69 d.Gefitinib.antiangio                     0.393000                      
70 -> direct                                      3.1 (0.81, 6.7)      
71 -> indirect                                    1.9 (0.68, 3.3)      
72 -> network                                     2.2 (1.1, 3.4)       
73 d.Lazertinib.Osimertinib              0.783500                      
74 -> direct                                      -0.34 (-1.8, 1.1)    
75 -> indirect                                    -0.0083 (-2.0, 2.1)  
76 -> network                                     -0.23 (-1.4, 0.94)   
77 d.Osimertinib.Placebo                 0.689950                      
78 -> direct                                      -0.55 (-2.2, 1.0)    
79 -> indirect                                    -0.12 (-1.7, 1.4)    
80 -> network                                     -0.31 (-1.4, 0.76)   
[2025-01-08 14:30:40]Saved diagnosis1 plot: 20250104-Consistency-SOC-vascular-total-netmeta.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 167
   Unobserved stochastic nodes: 167
   Total graph size: 3074

[1] "SOC-vascular-total-netmeta[2025-01-08 14:30:40]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair  i2.cons  incons.p
1                Afatinib            Afatinib_Cetuximab       NA       NA        NA
2                Afatinib             Chemotherapy 70.04302 27.96123 0.5551698
3                Afatinib                Erlotinib       NA  0.00000 0.9884136
4                Afatinib                Gefitinib       NA  0.00000 0.8104790
5                Afatinib                  Placebo       NA 47.24811 0.3220005
6            Almonertinib                Gefitinib       NA       NA        NA
7  Amivantamab_Lazertinib               Lazertinib       NA       NA        NA
8  Amivantamab_Lazertinib              Osimertinib       NA       NA        NA
9            Chemotherapy                Erlotinib 49.67864 52.35338 0.1011159
10           Chemotherapy   Erlotinib_chemotherapy       NA  0.00000 0.7862712
11           Chemotherapy                Gefitinib 59.14035 35.11432 0.1768632
12           Chemotherapy              Osimertinib       NA  0.00000 0.9373643
13            Dacomitinib                Erlotinib  0.00000  0.00000 0.9225131
14            Dacomitinib                Gefitinib       NA  0.00000 0.9129348
15            Dacomitinib                  Placebo       NA  0.00000 0.8654179
16                  DHFRi                Erlotinib       NA       NA        NA
17          Erlotinib_ERi                Gefitinib       NA       NA        NA
18          Erlotinib_ERi            Gefitinib_ERi       NA       NA        NA
19        Erlotinib_antiangio                    antiangio       NA  0.00000 0.8253582
20              Erlotinib     Erlotinib_Autophagyi       NA       NA        NA
21              Erlotinib   Erlotinib_chemotherapy  0.00000  0.00000        NA
22              Erlotinib          Erlotinib_COX2i       NA       NA        NA
23              Erlotinib            Erlotinib_ERi       NA       NA        NA
24              Erlotinib          Erlotinib_HER3i       NA       NA        NA
25              Erlotinib           Erlotinib_HGFi       NA       NA        NA
26              Erlotinib           Erlotinib_IGF_1Ri 75.81705 69.61594        NA
27              Erlotinib           Erlotinib_METi 41.20788 31.59158        NA
28              Erlotinib           Erlotinib_MMPi       NA       NA        NA
29              Erlotinib          Erlotinib_antiangio 84.86427 84.15354        NA
30              Erlotinib                Gefitinib       NA  0.00000 0.7083117
31              Erlotinib            Gefitinib_ERi       NA       NA        NA
32              Erlotinib                  Placebo  0.00000 57.27516 0.1842860
33              Erlotinib              Rociletinib       NA       NA        NA
34              Erlotinib                    antiangio 73.56535 71.38574 0.7480882
35    Gefitinib_Erlotinib              Osimertinib       NA       NA        NA
36              Gefitinib   Gefitinib_chemotherapy  0.00000  0.00000        NA
37              Gefitinib            Gefitinib_ERi       NA       NA        NA
38              Gefitinib          Gefitinib_antiangio 86.29712 81.31063        NA
39              Gefitinib               Lazertinib       NA  0.00000 0.8565774
40              Gefitinib                  Placebo 60.52973  0.00000 0.4264803
41              Gefitinib                    antiangio       NA  0.00000 0.5167945
42             Lazertinib              Osimertinib       NA  0.00000 0.8795878
43            Osimertinib Osimertinib_chemotherapy 55.21596 48.35064        NA
44            Osimertinib        Osimertinib_antiangio 53.16726 52.06108        NA
45            Osimertinib                   PD_L1i       NA       NA        NA
46            Osimertinib                  Placebo  0.00000  0.00000 0.7917472

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 69.67534 58.96762
[2025-01-08 14:30:40]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-vascular-total-netmeta.pdf
[1] "[2025-01-08 15:00:45]############################SOC-cardiac-serious-netmeta-gen######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 120
   Unobserved stochastic nodes: 142
   Total graph size: 2948

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 15:00:45]Saved forest plot: 20250104-gemtc-forest-SOC-cardiac-serious-netmeta-gen.pdf
[2025-01-08 15:00:45]Saved trace/density plot: 20250104-trace_density-SOC-cardiac-serious-netmeta-gen.pdf
[2025-01-08 15:00:45]Saved diagnosis plot: 20250104-gelman.plot-SOC-cardiac-serious-netmeta-gen.pdf
[1] "SOC-cardiac-serious-netmeta-gen[2025-01-08 15:00:45]: gelman.diag"
Potential scale reduction factors:

                Point est. Upper C.I.
d.Chemo.I             1.00       1.00
d.Chemo.I_Chemo       1.00       1.00
d.Chemo.II            1.00       1.00
d.Chemo.III           1.00       1.00
d.Gef_Erl.Zor         1.00       1.00
d.I.DHFRi             1.00       1.00
d.I.I_COX2i           1.33       2.02
d.I.I_HER3i           1.00       1.00
d.I.I_IGF_1Ri            1.00       1.00
d.I.I_METi            1.00       1.00
d.I.I_MMPi            1.19       1.50
d.I.I_PARPi           1.10       1.26
d.I.I_antiangio           1.00       1.00
d.I.Roc               1.00       1.00
d.I.antiangio             1.00       1.00
d.II.II_Cetuximab          1.00       1.00
d.II.II_HMGCRi        1.38       1.96
d.III.Gef_Erl         1.00       1.00
d.III.III_Chemo       1.00       1.00
d.III.III_antiangio       1.00       1.00
d.III.Placebo         1.00       1.00
sd.d                  1.00       1.00

Multivariate psrf

1.31
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 119
   Unobserved stochastic nodes: 142
   Total graph size: 3999

[1] "SOC-cardiac-serious-netmeta-gen[2025-01-08 15:00:45]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison      p.value  CrI                 
1  d.Chemo.I       0.759850                     
2  -> direct                -0.054 (-0.74, 0.62)
3  -> indirect              -0.32 (-1.7, 1.2)   
4  -> network               -0.10 (-0.69, 0.51) 
5  d.Chemo.I_Chemo 0.733350                     
6  -> direct                0.097 (-2.4, 2.4)   
7  -> indirect              0.51 (-0.84, 1.9)   
8  -> network               0.52 (-0.67, 1.7)   
9  d.Chemo.II      0.268375                     
10 -> direct                -1.3 (-3.6, 0.68)   
11 -> indirect              -0.088 (-0.96, 0.85)
12 -> network               -0.28 (-1.0, 0.50)  
13 d.Chemo.III     0.400025                     
14 -> direct                1.4 (-0.63, 4.5)    
15 -> indirect              0.40 (-0.58, 1.4)   
16 -> network               0.55 (-0.31, 1.5)   
17 d.I.II          0.612800                     
18 -> direct                -0.090 (-0.80, 0.59)
19 -> indirect              -0.41 (-1.6, 0.62)  
20 -> network               -0.17 (-0.75, 0.34) 
21 d.I.III         0.804275                     
22 -> direct                0.57 (-0.41, 1.6)   
23 -> indirect              0.74 (-0.33, 2.0)   
24 -> network               0.64 (-0.043, 1.4)  
25 d.I.Placebo     0.891850                     
26 -> direct                -0.34 (-1.2, 0.43)  
27 -> indirect              -0.24 (-1.2, 0.64)  
28 -> network               -0.27 (-0.88, 0.26) 
29 d.I_antiangio.antiangio 0.067850                     
30 -> direct                12. (1.5, 52.)      
31 -> indirect              1.6 (0.55, 2.9)     
32 -> network               1.8 (0.79, 3.1)     
33 d.II.Placebo    0.974150                     
34 -> direct                -0.11 (-1.2, 0.91)  
35 -> indirect              -0.11 (-1.1, 0.80)  
36 -> network               -0.098 (-0.77, 0.56)
37 d.III.Placebo   0.839650                     
38 -> direct                -0.84 (-2.2, 0.20)  
39 -> indirect              -1.0 (-2.2, 0.076)  
40 -> network               -0.92 (-1.7, -0.16) 
[2025-01-08 15:00:45]Saved diagnosis1 plot: 20250104-Consistency-SOC-cardiac-serious-netmeta-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 120
   Unobserved stochastic nodes: 120
   Total graph size: 2220

[1] "SOC-cardiac-serious-netmeta-gen[2025-01-08 15:00:45]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

        t1        t2  i2.pair   i2.cons  incons.p
1    Chemo         I 28.05665 19.868788 0.5221998
2    Chemo   I_Chemo       NA  0.000000 0.6967293
3    Chemo        II 46.43905  5.177523 0.3723183
4    Chemo       III       NA  0.000000 0.5473554
5    DHFRi         I       NA        NA        NA
6  Gef_Erl       III       NA        NA        NA
7  Gef_Erl       Zor       NA        NA        NA
8  I_antiangio     antiangio       NA  0.000000 0.2977128
9        I   I_Chemo  0.00000  0.000000        NA
10       I   I_COX2i       NA        NA        NA
11       I   I_HER3i       NA        NA        NA
12       I    I_IGF_1Ri 75.47267 74.036353        NA
13       I    I_METi  0.00000  0.000000        NA
14       I    I_MMPi       NA        NA        NA
15       I   I_PARPi       NA        NA        NA
16       I   I_antiangio 32.60948 32.264516        NA
17       I        II  0.00000  0.000000 0.7792287
18       I       III  0.00000  0.000000 0.8699073
19       I   Placebo  0.00000  0.000000 0.9047634
20       I       Roc       NA        NA        NA
21       I     antiangio 56.87684 58.677001        NA
22      II   II_Cetuximab       NA        NA        NA
23      II II_HMGCRi       NA        NA        NA
24      II   Placebo 74.57162 49.336301 0.9489932
25     III III_Chemo       NA        NA        NA
26     III III_antiangio 42.90139 42.710289        NA
27     III   Placebo 51.81112  8.376387 0.9344106

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 26.80093 18.63519
[2025-01-08 15:00:45]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-cardiac-serious-netmeta-gen.pdf
[1] "[2025-01-08 15:14:29]############################SOC-cardiac-total-netmeta-gen######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 138
   Unobserved stochastic nodes: 164
   Total graph size: 3509

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 15:14:29]Saved forest plot: 20250104-gemtc-forest-SOC-cardiac-total-netmeta-gen.pdf
[2025-01-08 15:14:29]Saved trace/density plot: 20250104-trace_density-SOC-cardiac-total-netmeta-gen.pdf
[2025-01-08 15:14:29]Saved diagnosis plot: 20250104-gelman.plot-SOC-cardiac-total-netmeta-gen.pdf
[1] "SOC-cardiac-total-netmeta-gen[2025-01-08 15:14:29]: gelman.diag"
Potential scale reduction factors:

                  Point est. Upper C.I.
d.Chemo.I               1.00       1.00
d.Chemo.I_Chemo         1.00       1.00
d.Chemo.II              1.00       1.00
d.Chemo.III             1.00       1.00
d.Gef_Erl.Zor           1.00       1.00
d.I.DHFRi               1.00       1.00
d.I.I_Autophagyi        1.00       1.00
d.I.I_COX2i             1.20       1.55
d.I.I_HER3i             1.00       1.00
d.I.I_HGFi              1.37       1.94
d.I.I_IGF_1Ri              1.00       1.00
d.I.I_METi              1.00       1.00
d.I.I_MMPi              1.00       1.00
d.I.I_PARPi             1.25       1.73
d.I.I_antiangio             1.00       1.00
d.I.Roc                 1.00       1.00
d.I.antiangio               1.00       1.00
d.II.II_Cetuximab            1.00       1.00
d.II.II_HMGCRi          1.00       1.00
d.III.Chemo_antiangio       1.10       1.27
d.III.Gef_Erl           1.00       1.00
d.III.III_Chemo         1.00       1.00
d.III.III_PD_L1i        1.28       1.82
d.III.III_antiangio         1.00       1.00
d.III.Placebo           1.00       1.00
sd.d                    1.00       1.00

Multivariate psrf

1.49
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 137
   Unobserved stochastic nodes: 164
   Total graph size: 4959

[1] "SOC-cardiac-total-netmeta-gen[2025-01-08 15:14:29]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison      p.value  CrI                 
1  d.Chemo.I       0.597725                     
2  -> direct                -0.15 (-0.69, 0.46) 
3  -> indirect              0.17 (-0.91, 1.3)   
4  -> network               -0.071 (-0.53, 0.39)
5  d.Chemo.I_Chemo 0.869650                     
6  -> direct                0.051 (-2.3, 2.4)   
7  -> indirect              0.23 (-0.70, 1.1)   
8  -> network               0.25 (-0.57, 1.2)   
9  d.Chemo.II      0.349625                     
10 -> direct                -1.2 (-3.4, 0.84)   
11 -> indirect              -0.24 (-0.91, 0.44) 
12 -> network               -0.35 (-1.0, 0.25)  
13 d.Chemo.III     0.177300                     
14 -> direct                1.1 (-0.22, 2.9)    
15 -> indirect              0.077 (-0.56, 0.74) 
16 -> network               0.22 (-0.30, 0.83)  
17 d.I.II          0.368200                     
18 -> direct                -0.17 (-0.71, 0.37) 
19 -> indirect              -0.63 (-1.6, 0.29)  
20 -> network               -0.29 (-0.76, 0.15) 
21 d.I.III         0.101075                     
22 -> direct                0.14 (-0.28, 0.54)  
23 -> indirect              0.88 (0.088, 1.7)   
24 -> network               0.29 (-0.056, 0.71) 
25 d.I.Placebo     0.418525                     
26 -> direct                -0.32 (-1.1, 0.41)  
27 -> indirect              -0.72 (-1.4, -0.050)
28 -> network               -0.55 (-1.0, -0.050)
29 d.I_antiangio.antiangio 0.622375                     
30 -> direct                2.5 (0.32, 5.7)     
31 -> indirect              1.8 (0.89, 2.9)     
32 -> network               2.0 (1.2, 3.0)      
33 d.II.Placebo    0.692575                     
34 -> direct                -0.097 (-1.2, 0.80) 
35 -> indirect              -0.35 (-1.1, 0.44)  
36 -> network               -0.25 (-0.82, 0.34) 
37 d.III.Placebo   0.253750                     
38 -> direct                -1.1 (-1.9, -0.41)  
39 -> indirect              -0.55 (-1.3, 0.16)  
40 -> network               -0.85 (-1.4, -0.36) 
[2025-01-08 15:14:29]Saved diagnosis1 plot: 20250104-Consistency-SOC-cardiac-total-netmeta-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 138
   Unobserved stochastic nodes: 138
   Total graph size: 2555

[1] "SOC-cardiac-total-netmeta-gen[2025-01-08 15:14:29]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

            t1           t2  i2.pair  i2.cons  incons.p
1  Chemo_antiangio          III       NA       NA        NA
2        Chemo            I 31.25014 23.09475 0.9237700
3        Chemo      I_Chemo       NA  0.00000 0.8288096
4        Chemo           II 49.00908  0.00000 0.3852681
5        Chemo          III       NA 35.82509 0.3180488
6        DHFRi            I       NA       NA        NA
7      Gef_Erl          III       NA       NA        NA
8      Gef_Erl          Zor       NA       NA        NA
9      I_antiangio        antiangio       NA  0.00000 0.6894368
10           I I_Autophagyi       NA       NA        NA
11           I      I_Chemo  0.00000  0.00000        NA
12           I      I_COX2i       NA       NA        NA
13           I      I_HER3i       NA       NA        NA
14           I       I_HGFi       NA       NA        NA
15           I       I_IGF_1Ri 68.90448 68.35074        NA
16           I       I_METi  0.00000  0.00000        NA
17           I       I_MMPi       NA       NA        NA
18           I      I_PARPi       NA       NA        NA
19           I      I_antiangio 29.55822 29.51338        NA
20           I           II  0.00000  0.00000 0.3842388
21           I          III  0.00000  0.00000 0.2018753
22           I      Placebo  0.00000  0.00000 0.4898043
23           I          Roc       NA       NA        NA
24           I        antiangio 59.70650 64.34088        NA
25          II      II_Cetuximab       NA       NA        NA
26          II    II_HMGCRi       NA       NA        NA
27          II      Placebo 74.30646 50.87202 0.7275225
28         III    III_Chemo 55.49183 55.78592        NA
29         III   III_PD_L1i       NA       NA        NA
30         III    III_antiangio 40.99194 40.98884        NA
31         III      Placebo 44.79252 23.29487 0.3646587

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 20.22294 19.67127
[2025-01-08 15:14:29]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-cardiac-total-netmeta-gen.pdf
[1] "[2025-01-08 15:30:29]############################SOC-vascular-serious-netmet-gen######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 154
   Unobserved stochastic nodes: 175
   Total graph size: 3570

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 15:30:29]Saved forest plot: 20250104-gemtc-forest-SOC-vascular-serious-netmet-gen.pdf
[2025-01-08 15:30:29]Saved trace/density plot: 20250104-trace_density-SOC-vascular-serious-netmet-gen.pdf
[2025-01-08 15:30:29]Saved diagnosis plot: 20250104-gelman.plot-SOC-vascular-serious-netmet-gen.pdf
[1] "SOC-vascular-serious-netmet-gen[2025-01-08 15:30:29]: gelman.diag"
Potential scale reduction factors:

                 Point est. Upper C.I.
d.Chemo.I              1.00       1.00
d.Chemo.I_Chemo        1.00       1.00
d.Chemo.II             1.00       1.00
d.Chemo.III            1.00       1.00
d.I.DHFRi              1.00       1.00
d.I.I_Autophagyi       1.02       1.06
d.I.I_ERi              1.11       1.28
d.I.I_HER3i            1.00       1.00
d.I.I_HGFi             1.06       1.15
d.I.I_IGF_1Ri             1.00       1.00
d.I.I_METi             1.00       1.00
d.I.I_MMPi             1.01       1.04
d.I.I_antiangio            1.00       1.00
d.I.Placebo            1.00       1.00
d.I.Roc                1.01       1.02
d.I.antiangio              1.00       1.00
d.II.II_Cetuximab           1.00       1.00
d.III.Gef_Erl          1.00       1.00
d.III.III_Chemo        1.00       1.00
d.III.III_antiangio        1.00       1.00
sd.d                   1.00       1.00

Multivariate psrf

1.11
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 153
   Unobserved stochastic nodes: 175
   Total graph size: 4534

[1] "SOC-vascular-serious-netmet-gen[2025-01-08 15:30:29]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison      p.value  CrI                  
1  d.Chemo.I       0.463050                      
2  -> direct                -0.49 (-1.6, 0.52)   
3  -> indirect              -1.3 (-3.1, 0.53)    
4  -> network               -0.66 (-1.6, 0.18)   
5  d.Chemo.I_Chemo 0.775350                      
6  -> direct                -0.92 (-4.9, 2.5)    
7  -> indirect              -0.38 (-1.9, 1.1)    
8  -> network               -0.44 (-1.8, 0.93)   
9  d.Chemo.II      0.955875                      
10 -> direct                -0.50 (-2.8, 1.7)    
11 -> indirect              -0.42 (-1.8, 0.89)   
12 -> network               -0.44 (-1.6, 0.66)   
13 d.Chemo.III     0.338375                      
14 -> direct                -0.36 (-2.7, 1.9)    
15 -> indirect              0.97 (-0.61, 2.6)    
16 -> network               0.53 (-0.75, 1.8)    
17 d.I.II          0.482525                      
18 -> direct                0.022 (-1.0, 1.1)    
19 -> indirect              0.67 (-0.90, 2.2)    
20 -> network               0.22 (-0.65, 1.1)    
21 d.I.III         0.135350                      
22 -> direct                1.9 (0.47, 3.6)      
23 -> indirect              0.22 (-1.5, 2.0)     
24 -> network               1.2 (0.087, 2.4)     
25 d.I.Placebo     0.834875                      
26 -> direct                0.057 (-1.2, 1.2)    
27 -> indirect              -0.15 (-1.7, 1.5)    
28 -> network               -0.0092 (-0.95, 0.92)
29 d.I_antiangio.antiangio 0.103950                      
30 -> direct                2.1 (-0.24, 4.6)     
31 -> indirect              -0.30 (-2.0, 1.5)    
32 -> network               0.72 (-0.67, 2.2)    
33 d.II.Placebo    0.378725                      
34 -> direct                -0.82 (-2.6, 0.89)   
35 -> indirect              0.18 (-1.3, 1.6)     
36 -> network               -0.23 (-1.3, 0.85)   
37 d.III.Placebo   0.423750                      
38 -> direct                -0.49 (-2.8, 1.7)    
39 -> indirect              -1.6 (-3.4, 0.0075)  
40 -> network               -1.2 (-2.6, 0.083)   
[2025-01-08 15:30:29]Saved diagnosis1 plot: 20250104-Consistency-SOC-vascular-serious-netmet-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 154
   Unobserved stochastic nodes: 154
   Total graph size: 2836

[1] "SOC-vascular-serious-netmet-gen[2025-01-08 15:30:29]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

        t1           t2   i2.pair  i2.cons  incons.p
1    Chemo            I 47.535613 46.42208 0.3111200
2    Chemo      I_Chemo        NA  0.00000 0.7575430
3    Chemo           II 63.215199 21.25487 0.9394117
4    Chemo          III        NA 67.21222 0.3745935
5    DHFRi            I        NA       NA        NA
6  Gef_Erl          III        NA       NA        NA
7  I_antiangio        antiangio        NA 76.32365 0.1835546
8        I I_Autophagyi        NA       NA        NA
9        I      I_Chemo  0.000000  0.00000        NA
10       I        I_ERi        NA       NA        NA
11       I      I_HER3i        NA       NA        NA
12       I       I_HGFi        NA       NA        NA
13       I       I_IGF_1Ri 59.892005 60.05242        NA
14       I       I_METi 11.562470 11.27879        NA
15       I       I_MMPi        NA       NA        NA
16       I      I_antiangio 79.511883 78.61458        NA
17       I           II  0.000000  0.00000 0.5061943
18       I          III 85.729813 68.67867 0.1871254
19       I      Placebo  8.018804  0.00000 0.8237407
20       I          Roc        NA       NA        NA
21       I        antiangio 85.016876 95.21624        NA
22      II      II_Cetuximab        NA       NA        NA
23      II      Placebo 46.219204 29.48120 0.3924209
24     III    III_Chemo 52.439193 52.90036        NA
25     III    III_antiangio 62.309528 62.46905        NA
26     III      Placebo  0.000000  0.00000 0.4564337

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 67.08677 66.15276
[2025-01-08 15:30:29]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-vascular-serious-netmet-gen.pdf
[1] "[2025-01-08 15:47:36]############################SOC-vascular-total-netmeta-gen######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 164
   Unobserved stochastic nodes: 187
   Total graph size: 3860

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 15:47:36]Saved forest plot: 20250104-gemtc-forest-SOC-vascular-total-netmeta-gen.pdf
[2025-01-08 15:47:36]Saved trace/density plot: 20250104-trace_density-SOC-vascular-total-netmeta-gen.pdf
[2025-01-08 15:47:36]Saved diagnosis plot: 20250104-gelman.plot-SOC-vascular-total-netmeta-gen.pdf
[1] "SOC-vascular-total-netmeta-gen[2025-01-08 15:47:36]: gelman.diag"
Potential scale reduction factors:

                 Point est. Upper C.I.
d.Chemo.I              1.00       1.00
d.Chemo.I_Chemo        1.00       1.00
d.Chemo.II             1.00       1.00
d.Chemo.III            1.00       1.00
d.I.DHFRi              1.00       1.00
d.I.I_Autophagyi       1.00       1.00
d.I.I_COX2i            1.06       1.17
d.I.I_ERi              1.00       1.00
d.I.I_HER3i            1.00       1.00
d.I.I_HGFi             1.00       1.00
d.I.I_IGF_1Ri             1.00       1.00
d.I.I_METi             1.00       1.00
d.I.I_MMPi             1.00       1.00
d.I.I_antiangio            1.00       1.00
d.I.Placebo            1.00       1.00
d.I.Rociletinib        1.27       1.73
d.I.antiangio              1.00       1.00
d.II.II_Cetuximab           1.00       1.00
d.III.Gef_Erl          1.00       1.00
d.III.III_Chemo        1.00       1.00
d.III.III_antiangio        1.00       1.00
d.III.PD_L1i           1.00       1.00
sd.d                   1.00       1.00

Multivariate psrf

1.18
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 163
   Unobserved stochastic nodes: 187
   Total graph size: 5007

[1] "SOC-vascular-total-netmeta-gen[2025-01-08 15:47:36]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison      p.value  CrI                 
1  d.Chemo.I       0.320000                     
2  -> direct                -0.64 (-1.5, 0.13)  
3  -> indirect              -1.4 (-2.8, -0.094) 
4  -> network               -0.84 (-1.5, -0.17) 
5  d.Chemo.I_Chemo 0.845700                     
6  -> direct                -0.87 (-4.6, 2.2)   
7  -> indirect              -0.55 (-1.6, 0.50)  
8  -> network               -0.59 (-1.6, 0.40)  
9  d.Chemo.II      0.783725                     
10 -> direct                -0.90 (-2.6, 0.70)  
11 -> indirect              -0.64 (-1.7, 0.41)  
12 -> network               -0.71 (-1.6, 0.15)  
13 d.Chemo.III     0.277525                     
14 -> direct                -0.67 (-2.4, 1.1)   
15 -> indirect              0.46 (-0.71, 1.6)   
16 -> network               0.11 (-0.86, 1.0)   
17 d.I.II          0.511575                     
18 -> direct                -0.033 (-0.88, 0.81)
19 -> indirect              0.45 (-0.75, 1.7)   
20 -> network               0.13 (-0.57, 0.81)  
21 d.I.III         0.145125                     
22 -> direct                1.4 (0.38, 2.4)     
23 -> indirect              0.16 (-1.2, 1.5)    
24 -> network               0.94 (0.14, 1.8)    
25 d.I.Placebo     0.676250                     
26 -> direct                0.043 (-0.93, 0.97) 
27 -> indirect              -0.28 (-1.5, 0.97)  
28 -> network               -0.072 (-0.84, 0.67)
29 d.I_antiangio.antiangio 0.694050                     
30 -> direct                0.69 (-1.2, 2.6)    
31 -> indirect              0.22 (-1.2, 1.7)    
32 -> network               0.43 (-0.65, 1.5)   
33 d.II.Placebo    0.281500                     
34 -> direct                -0.79 (-2.2, 0.61)  
35 -> indirect              0.18 (-0.94, 1.3)   
36 -> network               -0.20 (-1.1, 0.67)  
37 d.III.Placebo   0.498975                     
38 -> direct                -0.51 (-2.3, 1.2)   
39 -> indirect              -1.2 (-2.5, -0.053) 
40 -> network               -1.0 (-2.0, -0.034) 
[2025-01-08 15:47:36]Saved diagnosis1 plot: 20250104-Consistency-SOC-vascular-total-netmeta-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 164
   Unobserved stochastic nodes: 164
   Total graph size: 3020

[1] "SOC-vascular-total-netmeta-gen[2025-01-08 15:47:36]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

        t1           t2   i2.pair   i2.cons  incons.p
1    Chemo            I 44.269781 47.930242 0.2043384
2    Chemo      I_Chemo        NA  0.000000 0.8170108
3    Chemo           II 59.999689  0.000000 0.7975495
4    Chemo          III        NA 80.124883 0.3104523
5    DHFRi            I        NA        NA        NA
6  Gef_Erl          III        NA        NA        NA
7  I_antiangio        antiangio        NA  0.000000 0.7523172
8        I I_Autophagyi        NA        NA        NA
9        I      I_Chemo  0.000000  0.000000        NA
10       I      I_COX2i        NA        NA        NA
11       I        I_ERi        NA        NA        NA
12       I      I_HER3i        NA        NA        NA
13       I       I_HGFi        NA        NA        NA
14       I       I_IGF_1Ri 78.173784 78.517006        NA
15       I       I_METi 40.496641 40.465855        NA
16       I       I_MMPi        NA        NA        NA
17       I      I_antiangio 86.248195 85.911990        NA
18       I           II  0.000000  0.000000 0.5803328
19       I          III 91.733211 83.585210 0.2118398
20       I      Placebo  3.497555  6.131836 0.7466981
21       I  Rociletinib        NA        NA        NA
22       I        antiangio 78.465393 80.347575        NA
23      II      II_Cetuximab        NA        NA        NA
24      II      Placebo 43.643920 33.834527 0.3197542
25     III    III_Chemo 63.710963 62.446002        NA
26     III    III_antiangio 53.800309 54.130971        NA
27     III       PD_L1i        NA        NA        NA
28     III      Placebo  0.000000  0.000000 0.5104167

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 71.22993 67.84764
[2025-01-08 15:47:36]Saved diagnosis1 plot: 20250104-Heterogeneity-SOC-vascular-total-netmeta-gen.pdf
Current Category: secondary 
[1] "[2025-01-08 16:05:40]############################serious-arrhythmias######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 93
   Unobserved stochastic nodes: 118
   Total graph size: 2560

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 16:05:40]Saved forest plot: 20250104-gemtc-forest-serious-arrhythmias.pdf
[2025-01-08 16:05:40]Saved trace/density plot: 20250104-trace_density-serious-arrhythmias.pdf
[2025-01-08 16:05:40]Saved diagnosis plot: 20250104-gelman.plot-serious-arrhythmias.pdf
[1] "serious-arrhythmias[2025-01-08 16:05:40]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.01       1.01
d.Afatinib.Afatinib_HMGCRi                   1.02       1.05
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Erlotinib_chemotherapy        1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Rociletinib                      1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib_Erlotinib.Zorifertinib           1.00       1.00
d.Gefitinib.Almonertinib                     1.00       1.00
d.Gefitinib.Furmonertinib                    1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Lazertinib                     1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.10       1.26
d.Osimertinib.Placebo                        1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.06
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 93
   Unobserved stochastic nodes: 119
   Total graph size: 3924

[1] "serious-arrhythmias[2025-01-08 16:05:40]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                            p.value  CrI               
1  d.Afatinib.Chemotherapy               0.041850                   
2  -> direct                                      24. (0.95, 80.)   
3  -> indirect                                    0.068 (-2.2, 3.7) 
4  -> network                                     0.78 (-1.4, 4.7)  
5  d.Afatinib.Erlotinib                  0.138225                   
6  -> direct                                      -0.99 (-4.5, 2.4) 
7  -> indirect                                    2.0 (-0.95, 6.8)  
8  -> network                                     0.17 (-1.7, 3.4)  
9  d.Afatinib.Gefitinib                  0.044500                   
10 -> direct                                      19. (0.25, 56.)   
11 -> indirect                                    -0.81 (-3.8, 3.4) 
12 -> network                                     0.25 (-2.4, 4.5)  
13 d.Afatinib.Placebo                    0.979050                   
14 -> direct                                      -1.3 (-5.9, 2.7)  
15 -> indirect                                    -1.4 (-4.9, 2.6)  
16 -> network                                     -1.3 (-3.9, 1.4)  
17 d.Chemotherapy.Erlotinib              0.888500                   
18 -> direct                                      -0.70 (-3.9, 1.6) 
19 -> indirect                                    -0.99 (-5.9, 2.6) 
20 -> network                                     -0.58 (-2.9, 1.1) 
21 d.Chemotherapy.Erlotinib_chemotherapy 0.849200                   
22 -> direct                                      -0.019 (-5.0, 4.9)
23 -> indirect                                    0.57 (-4.6, 5.8)  
24 -> network                                     0.49 (-2.7, 3.7)  
25 d.Chemotherapy.Gefitinib              0.745125                   
26 -> direct                                      -0.87 (-5.0, 2.3) 
27 -> indirect                                    -0.049 (-4.2, 5.1)
28 -> network                                     -0.52 (-3.1, 1.9) 
29 d.Chemotherapy.Osimertinib            0.312775                   
30 -> direct                                      0.66 (-3.5, 5.4)  
31 -> indirect                                    -1.9 (-7.1, 1.6)  
32 -> network                                     -0.58 (-3.7, 1.8) 
33 d.Dacomitinib.Erlotinib               0.445775                   
34 -> direct                                      0.44 (-3.3, 4.1)  
35 -> indirect                                    2.7 (-2.5, 8.6)   
36 -> network                                     0.96 (-1.5, 4.1)  
37 d.Dacomitinib.Placebo                 0.443625                   
38 -> direct                                      0.72 (-4.2, 5.6)  
39 -> indirect                                    -1.4 (-6.6, 2.4)  
40 -> network                                     -0.53 (-3.8, 2.3) 
41 d.Erlotinib.Placebo                   0.555000                   
42 -> direct                                      -2.2 (-6.6, 0.39) 
43 -> indirect                                    -1.1 (-4.7, 1.8)  
44 -> network                                     -1.5 (-4.3, 0.26) 
45 d.Erlotinib.antiangio                     0.012650                   
46 -> direct                                      1.5 (-0.26, 4.2)  
47 -> indirect                                    16. (3.7, 76.)    
48 -> network                                     2.8 (0.88, 6.7)   
49 d.Erlotinib_antiangio.antiangio               0.049550                   
50 -> direct                                      35. (2.3, 1.2e+02)
51 -> indirect                                    1.9 (-1.3, 5.5)   
52 -> network                                     2.5 (0.032, 6.4)  
53 d.Gefitinib.Lazertinib                0.015475                   
54 -> direct                                      -28. (-95., -0.61)
55 -> indirect                                    2.8 (-2.2, 8.1)   
56 -> network                                     0.18 (-4.6, 3.8)  
57 d.Gefitinib.antiangio                     0.003150                   
58 -> direct                                      27. (6.3, 55.)    
59 -> indirect                                    0.60 (-2.5, 4.1)  
60 -> network                                     2.7 (0.18, 7.0)   
61 d.Lazertinib.Osimertinib              0.002975                   
62 -> direct                                      -1.6 (-5.9, 2.0)  
63 -> indirect                                    63. (6.1, 1.5e+02)
64 -> network                                     -0.21 (-3.5, 3.6) 
65 d.Osimertinib.Placebo                 0.968525                   
66 -> direct                                      -1.6 (-5.7, 1.4)  
67 -> indirect                                    -1.6 (-7.2, 2.7)  
68 -> network                                     -1.5 (-4.6, 0.67) 
[2025-01-08 16:05:40]Saved diagnosis1 plot: 20250104-Consistency-serious-arrhythmias.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 93
   Unobserved stochastic nodes: 93
   Total graph size: 1717

[1] "serious-arrhythmias[2025-01-08 16:05:40]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair  i2.cons   incons.p
1                Afatinib            Afatinib_Cetuximab       NA       NA         NA
2                Afatinib          Afatinib_HMGCRi       NA       NA         NA
3                Afatinib             Chemotherapy       NA 44.58333 0.24082538
4                Afatinib                Erlotinib       NA 71.75783 0.70783635
5                Afatinib                Gefitinib       NA 43.41196 0.01089654
6                Afatinib                  Placebo       NA  0.00000 0.97531741
7            Almonertinib                Gefitinib       NA       NA         NA
8  Amivantamab_Lazertinib               Lazertinib       NA       NA         NA
9  Amivantamab_Lazertinib              Osimertinib       NA       NA         NA
10           Chemotherapy                Erlotinib 30.21547 20.91070 0.86199783
11           Chemotherapy   Erlotinib_chemotherapy       NA  0.00000 0.87013993
12           Chemotherapy                Gefitinib 54.46061  0.00000 0.89723689
13           Chemotherapy              Osimertinib       NA  0.00000 0.68806299
14            Dacomitinib                Erlotinib       NA  0.00000 0.85658411
15            Dacomitinib                  Placebo       NA  0.00000 0.72225893
16                  DHFRi                Erlotinib       NA       NA         NA
17        Erlotinib_antiangio                    antiangio       NA  0.00000 0.37048244
18              Erlotinib   Erlotinib_chemotherapy  0.00000  0.00000         NA
19              Erlotinib          Erlotinib_HER3i       NA       NA         NA
20              Erlotinib           Erlotinib_IGF_1Ri 56.33480 54.10276         NA
21              Erlotinib           Erlotinib_METi 17.43168 16.06740         NA
22              Erlotinib          Erlotinib_antiangio 21.01992 10.61844         NA
23              Erlotinib                  Placebo 59.49357 23.39662 0.77515069
24              Erlotinib              Rociletinib       NA       NA         NA
25              Erlotinib                    antiangio 34.20340 76.18866 0.65327380
26          Furmonertinib                Gefitinib       NA       NA         NA
27    Gefitinib_Erlotinib              Osimertinib       NA       NA         NA
28    Gefitinib_Erlotinib             Zorifertinib       NA       NA         NA
29              Gefitinib               Lazertinib       NA 43.60178 0.26706160
30              Gefitinib                    antiangio       NA 49.83120 0.19504000
31             Lazertinib              Osimertinib       NA  0.00000 0.65995280
32            Osimertinib Osimertinib_chemotherapy       NA       NA         NA
33            Osimertinib        Osimertinib_antiangio  0.00000  0.00000         NA
34            Osimertinib                  Placebo 41.37463  0.00000 0.95995979

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 87.84505 41.17395
[2025-01-08 16:05:40]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-arrhythmias.pdf
[1] "[2025-01-08 16:19:24]############################serious-heart failure######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 67
   Unobserved stochastic nodes: 90
   Total graph size: 1931

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 16:19:24]Saved forest plot: 20250104-gemtc-forest-serious-heart failure.pdf
[2025-01-08 16:19:24]Saved trace/density plot: 20250104-trace_density-serious-heart failure.pdf
[2025-01-08 16:19:24]Saved diagnosis plot: 20250104-gelman.plot-serious-heart failure.pdf
[1] "serious-heart failure[2025-01-08 16:19:24]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.Erlotinib_chemotherapy           1.00       1.00
d.Erlotinib.Erlotinib_HER3i                  1.01       1.02
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.01       1.01
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.antiangio                            1.01       1.01
d.Gefitinib.Almonertinib                     1.02       1.05
d.Gefitinib.Gefitinib_chemotherapy           1.01       1.03
d.Gefitinib.Gefitinib_PARPi                  1.00       1.00
d.Gefitinib.Icotinib                         1.01       1.02
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.03       1.08
d.Osimertinib.Osimertinib_antiangio              1.03       1.06
sd.d                                         1.00       1.00

Multivariate psrf

1.04
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 67
   Unobserved stochastic nodes: 91
   Total graph size: 3098

[1] "serious-heart failure[2025-01-08 16:19:24]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                 p.value  CrI               
1  d.Afatinib.Chemotherapy    0.039900                   
2  -> direct                           15. (0.44, 46.)   
3  -> indirect                         -1.4 (-6.6, 3.7)  
4  -> network                          0.88 (-2.8, 5.1)  
5  d.Afatinib.Erlotinib       0.493225                   
6  -> direct                           0.32 (-3.4, 4.0)  
7  -> indirect                         2.3 (-2.4, 8.2)   
8  -> network                          0.93 (-1.7, 4.0)  
9  d.Afatinib.Placebo         0.692950                   
10 -> direct                           -1.0 (-5.6, 2.9)  
11 -> indirect                         0.12 (-4.8, 4.6)  
12 -> network                          -0.51 (-3.6, 2.3) 
13 d.Chemotherapy.Erlotinib   0.027525                   
14 -> direct                           -20. (-69., 0.051)
15 -> indirect                         2.3 (-2.6, 8.1)   
16 -> network                          0.082 (-4.0, 3.9) 
17 d.Chemotherapy.Gefitinib   0.003775                   
18 -> direct                           18. (0.17, 56.)   
19 -> indirect                         -18. (-56., -0.86)
20 -> network                          0.15 (-4.9, 6.0)  
21 d.Chemotherapy.Osimertinib 0.032325                   
22 -> direct                           15. (0.031, 56.)  
23 -> indirect                         -2.0 (-7.7, 3.0)  
24 -> network                          0.58 (-2.9, 4.9)  
25 d.Erlotinib.Placebo        0.009000                   
26 -> direct                           -25. (-69., -2.5) 
27 -> indirect                         1.3 (-2.9, 6.5)   
28 -> network                          -1.4 (-4.9, 1.2)  
29 d.Gefitinib.Lazertinib     0.007250                   
30 -> direct                           12. (-0.81, 49.)  
31 -> indirect                         -18. (-64., -0.24)
32 -> network                          0.28 (-4.7, 6.2)  
33 d.Lazertinib.Osimertinib   0.005175                   
34 -> direct                           1.2 (-2.3, 5.6)   
35 -> indirect                         -31. (-77., -5.0) 
36 -> network                          0.086 (-3.7, 3.7) 
37 d.Osimertinib.Placebo      0.000100                   
38 -> direct                           -0.11 (-3.0, 2.3) 
39 -> indirect                         -40. (-74., -16.) 
40 -> network                          -2.0 (-5.8, 0.67) 
[2025-01-08 16:19:24]Saved diagnosis1 plot: 20250104-Consistency-serious-heart failure.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 67
   Unobserved stochastic nodes: 67
   Total graph size: 1238

[1] "serious-heart failure[2025-01-08 16:19:24]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair  i2.cons   incons.p
1                Afatinib             Chemotherapy       NA 44.44371 0.26483645
2                Afatinib                Erlotinib       NA 61.75195 0.12860647
3                Afatinib                  Placebo       NA  0.00000 0.62296844
4            Almonertinib                Gefitinib       NA       NA         NA
5  Amivantamab_Lazertinib               Lazertinib       NA       NA         NA
6  Amivantamab_Lazertinib              Osimertinib       NA       NA         NA
7            Chemotherapy                Erlotinib       NA 43.32443 0.25351904
8            Chemotherapy                Gefitinib       NA 43.64212 0.29030908
9            Chemotherapy              Osimertinib       NA 47.52425 0.23234843
10            Dacomitinib                Erlotinib       NA       NA         NA
11              Erlotinib   Erlotinib_chemotherapy       NA       NA         NA
12              Erlotinib          Erlotinib_HER3i       NA       NA         NA
13              Erlotinib           Erlotinib_IGF_1Ri       NA       NA         NA
14              Erlotinib           Erlotinib_METi  0.00000  0.00000         NA
15              Erlotinib           Erlotinib_MMPi       NA       NA         NA
16              Erlotinib          Erlotinib_antiangio 31.39989 32.09744         NA
17              Erlotinib                  Placebo  0.00000 35.18450 0.10720812
18              Erlotinib                    antiangio       NA       NA         NA
19    Gefitinib_Erlotinib              Osimertinib       NA       NA         NA
20              Gefitinib   Gefitinib_chemotherapy       NA       NA         NA
21              Gefitinib          Gefitinib_PARPi       NA       NA         NA
22              Gefitinib                 Icotinib       NA       NA         NA
23              Gefitinib               Lazertinib       NA 41.49097 0.14697270
24             Lazertinib              Osimertinib       NA 72.36610 0.06575002
25            Osimertinib Osimertinib_chemotherapy       NA       NA         NA
26            Osimertinib        Osimertinib_antiangio       NA       NA         NA
27            Osimertinib                  Placebo 50.99342 86.25679         NA

Global I-squared:
-------------------------

  i2.pair  i2.cons
1 9.78124 55.05406
[2025-01-08 16:19:24]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-heart failure.pdf
[1] "[2025-01-08 16:26:57]############################serious-Vascular Toxicity######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 140
   Unobserved stochastic nodes: 168
   Total graph size: 3657

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 16:26:57]Saved forest plot: 20250104-gemtc-forest-serious-Vascular Toxicity.pdf
[2025-01-08 16:26:57]Saved trace/density plot: 20250104-trace_density-serious-Vascular Toxicity.pdf
[2025-01-08 16:26:57]Saved diagnosis plot: 20250104-gelman.plot-serious-Vascular Toxicity.pdf
[1] "serious-Vascular Toxicity[2025-01-08 16:26:57]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.24       1.71
d.Erlotinib.Erlotinib_chemotherapy           1.00       1.00
d.Erlotinib.Erlotinib_COX2i                  1.04       1.10
d.Erlotinib.Erlotinib_ERi                    1.22       1.61
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_HGFi                   1.17       1.47
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.01
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.00       1.00
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Rociletinib                      1.00       1.01
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib.Almonertinib                     1.02       1.05
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
sd.d                                         1.00       1.01

Multivariate psrf

1.26
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 140
   Unobserved stochastic nodes: 169
   Total graph size: 5353

[1] "serious-Vascular Toxicity[2025-01-08 16:26:57]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                 p.value  CrI                
1  d.Afatinib.Chemotherapy    0.375375                    
2  -> direct                           0.56 (-0.76, 1.9)  
3  -> indirect                         -0.11 (-1.1, 0.76) 
4  -> network                          0.15 (-0.63, 0.89) 
5  d.Afatinib.Erlotinib       0.561400                    
6  -> direct                           0.0044 (-1.0, 0.99)
7  -> indirect                         -0.39 (-1.4, 0.62) 
8  -> network                          -0.16 (-0.84, 0.53)
9  d.Afatinib.Gefitinib       0.762375                    
10 -> direct                           -0.63 (-1.9, 0.53) 
11 -> indirect                         -0.40 (-1.6, 0.71) 
12 -> network                          -0.50 (-1.3, 0.24) 
13 d.Afatinib.Placebo         0.205825                    
14 -> direct                           -1.3 (-3.5, 0.14)  
15 -> indirect                         -0.21 (-1.1, 0.63) 
16 -> network                          -0.47 (-1.2, 0.28) 
17 d.Chemotherapy.Erlotinib   0.209850                    
18 -> direct                           0.020 (-0.75, 0.83)
19 -> indirect                         -0.87 (-2.0, 0.24) 
20 -> network                          -0.32 (-0.91, 0.33)
21 d.Chemotherapy.Gefitinib   0.899875                    
22 -> direct                           -0.70 (-2.2, 0.71) 
23 -> indirect                         -0.55 (-1.6, 0.54) 
24 -> network                          -0.65 (-1.5, 0.098)
25 d.Chemotherapy.Osimertinib 0.546175                    
26 -> direct                           -0.36 (-1.5, 0.91) 
27 -> indirect                         0.19 (-1.0, 1.4)   
28 -> network                          -0.15 (-1.0, 0.74) 
29 d.Dacomitinib.Erlotinib    0.235775                    
30 -> direct                           0.53 (-0.39, 1.6)  
31 -> indirect                         -0.42 (-1.8, 0.85) 
32 -> network                          0.20 (-0.53, 0.97) 
33 d.Dacomitinib.Gefitinib    0.567950                    
34 -> direct                           -0.82 (-4.3, 1.8)  
35 -> indirect                         -0.0029 (-1.1, 1.1)
36 -> network                          -0.14 (-1.1, 0.82) 
37 d.Dacomitinib.Placebo      0.346350                    
38 -> direct                           -0.54 (-2.1, 0.71) 
39 -> indirect                         0.25 (-0.88, 1.3)  
40 -> network                          -0.11 (-0.92, 0.70)
41 d.Erlotinib.Placebo        0.011550                    
42 -> direct                           0.36 (-0.41, 1.1)  
43 -> indirect                         -1.2 (-2.1, -0.32) 
44 -> network                          -0.31 (-0.92, 0.29)
45 d.Erlotinib_antiangio.antiangio    0.304475                    
46 -> direct                           0.97 (-0.68, 3.2)  
47 -> indirect                         -0.047 (-1.0, 0.96)
48 -> network                          0.34 (-0.54, 1.4)  
49 d.Gefitinib.Lazertinib     0.771425                    
50 -> direct                           0.98 (-0.35, 2.5)  
51 -> indirect                         0.69 (-0.87, 2.3)  
52 -> network                          0.85 (-0.12, 1.9)  
53 d.Gefitinib.Placebo        0.210075                    
54 -> direct                           -0.74 (-2.5, 0.72) 
55 -> indirect                         0.37 (-0.55, 1.3)  
56 -> network                          0.041 (-0.75, 0.84)
57 d.Lazertinib.Osimertinib   0.716200                    
58 -> direct                           -0.30 (-1.3, 0.74) 
59 -> indirect                         -0.67 (-2.5, 1.1)  
60 -> network                          -0.34 (-1.2, 0.53) 
61 d.Osimertinib.Placebo      0.679050                    
62 -> direct                           -0.62 (-2.0, 0.58) 
63 -> indirect                         -0.29 (-1.6, 0.92) 
64 -> network                          -0.48 (-1.3, 0.40) 
[2025-01-08 16:26:57]Saved diagnosis1 plot: 20250104-Consistency-serious-Vascular Toxicity.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 140
   Unobserved stochastic nodes: 140
   Total graph size: 2582

[1] "serious-Vascular Toxicity[2025-01-08 16:26:57]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2   i2.pair   i2.cons  incons.p
1                Afatinib            Afatinib_Cetuximab        NA        NA        NA
2                Afatinib             Chemotherapy 46.557049  0.000000 0.4154388
3                Afatinib                Erlotinib        NA  0.000000 0.6348988
4                Afatinib                Gefitinib        NA  0.000000 0.7359396
5                Afatinib                  Placebo        NA 30.540650 0.2711179
6            Almonertinib                Gefitinib        NA        NA        NA
7  Amivantamab_Lazertinib               Lazertinib        NA        NA        NA
8  Amivantamab_Lazertinib              Osimertinib        NA        NA        NA
9            Chemotherapy                Erlotinib 56.486696 47.470771 0.3088924
10           Chemotherapy                Gefitinib 49.137850 29.538356 0.8428512
11           Chemotherapy              Osimertinib        NA  0.000000 0.5774704
12            Dacomitinib                Erlotinib 15.061550  0.000000 0.3704155
13            Dacomitinib                Gefitinib        NA  0.000000 0.5929753
14            Dacomitinib                  Placebo        NA  0.000000 0.4214921
15                  DHFRi                Erlotinib        NA        NA        NA
16        Erlotinib_antiangio                    antiangio        NA  0.000000 0.4014262
17              Erlotinib     Erlotinib_Autophagyi        NA        NA        NA
18              Erlotinib   Erlotinib_chemotherapy 36.123578 34.807369        NA
19              Erlotinib          Erlotinib_COX2i        NA        NA        NA
20              Erlotinib            Erlotinib_ERi        NA        NA        NA
21              Erlotinib          Erlotinib_HER3i        NA        NA        NA
22              Erlotinib           Erlotinib_HGFi        NA        NA        NA
23              Erlotinib           Erlotinib_IGF_1Ri 53.616784 53.617444        NA
24              Erlotinib           Erlotinib_METi  0.000000  0.000000        NA
25              Erlotinib           Erlotinib_MMPi        NA        NA        NA
26              Erlotinib          Erlotinib_antiangio  5.194243  5.146081        NA
27              Erlotinib                  Placebo  3.625549 62.233396 0.0288813
28              Erlotinib              Rociletinib        NA        NA        NA
29              Erlotinib                    antiangio 17.610578 51.992030        NA
30    Gefitinib_Erlotinib              Osimertinib        NA        NA        NA
31              Gefitinib   Gefitinib_chemotherapy 11.857914 12.455386        NA
32              Gefitinib               Lazertinib        NA  0.000000 0.8217734
33              Gefitinib                  Placebo 43.842953 27.302479 0.2179145
34             Lazertinib              Osimertinib        NA  0.000000 0.8793495
35            Osimertinib Osimertinib_chemotherapy        NA        NA        NA
36            Osimertinib        Osimertinib_antiangio        NA        NA        NA
37            Osimertinib                  Placebo  0.000000  0.000000 0.7301064

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 28.58532 20.94445
[2025-01-08 16:26:57]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-Vascular Toxicity.pdf
[1] "[2025-01-08 16:47:04]############################serious-hypertension######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 73
   Unobserved stochastic nodes: 91
   Total graph size: 1847

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 16:47:04]Saved forest plot: 20250104-gemtc-forest-serious-hypertension.pdf
[2025-01-08 16:47:04]Saved trace/density plot: 20250104-trace_density-serious-hypertension.pdf
[2025-01-08 16:47:04]Saved diagnosis plot: 20250104-gelman.plot-serious-hypertension.pdf
[1] "serious-hypertension[2025-01-08 16:47:04]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.01       1.02
d.Erlotinib.Chemotherapy                     1.03       1.08
d.Erlotinib.Erlotinib_IGF_1Ri                   1.04       1.10
d.Erlotinib.Erlotinib_METi                   1.01       1.03
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib.Dacomitinib                      1.00       1.00
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_antiangio                  1.00       1.00
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.02       1.05
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
d.Placebo.Afatinib                           1.00       1.00
d.Placebo.Erlotinib                          1.00       1.00
d.Placebo.Gefitinib                          1.00       1.00
d.Placebo.Osimertinib                        1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.04
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 73
   Unobserved stochastic nodes: 92
   Total graph size: 2582

[1] "serious-hypertension[2025-01-08 16:47:04]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison               p.value  CrI                   
1  d.Afatinib.Erlotinib     0.034575                       
2  -> direct                         25. (-0.032, 75.)     
3  -> indirect                       -1.6 (-7.2, 3.3)      
4  -> network                        0.44 (-3.1, 4.7)      
5  d.Afatinib.Gefitinib     0.063425                       
6  -> direct                         25. (0.80, 80.)       
7  -> indirect                       0.57 (-4.9, 5.9)      
8  -> network                        1.8 (-1.8, 6.2)       
9  d.Afatinib.Placebo       0.002825                       
10 -> direct                         -27. (-1.1e+02, -0.13)
11 -> indirect                       21. (2.8, 70.)        
12 -> network                        1.6 (-2.1, 5.8)       
13 d.Erlotinib.Placebo      0.002450                       
14 -> direct                         26. (3.1, 61.)        
15 -> indirect                       -2.5 (-8.6, 2.7)      
16 -> network                        1.2 (-2.0, 4.5)       
17 d.Erlotinib.antiangio        0.393425                       
18 -> direct                         3.4 (1.3, 6.6)        
19 -> indirect                       6.4 (-0.033, 14.)     
20 -> network                        4.0 (2.2, 6.2)        
21 d.Erlotinib_antiangio.antiangio  0.380775                       
22 -> direct                         3.0 (-0.32, 7.2)      
23 -> indirect                       1.2 (-1.6, 4.3)       
24 -> network                        2.0 (0.12, 4.1)       
25 d.Gefitinib.Lazertinib   0.000000                       
26 -> direct                         -33. (-1.1e+02, -1.3) 
27 -> indirect                       65. (13., 1.6e+02)    
28 -> network                        0.15 (-6.1, 5.3)      
29 d.Gefitinib.Placebo      0.026325                       
30 -> direct                         19. (-0.37, 70.)      
31 -> indirect                       -2.2 (-8.4, 2.0)      
32 -> network                        -0.16 (-3.6, 3.1)     
33 d.Gefitinib.antiangio        0.447575                       
34 -> direct                         3.2 (-0.023, 7.0)     
35 -> indirect                       0.76 (-6.1, 6.7)      
36 -> network                        2.6 (0.083, 5.5)      
37 d.Lazertinib.Osimertinib 0.000000                       
38 -> direct                         -40. (-95., -3.3)     
39 -> indirect                       60. (11., 1.3e+02)    
40 -> network                        -0.46 (-5.9, 4.3)     
41 d.Osimertinib.Placebo    0.000000                       
42 -> direct                         -33. (-83., -0.69)    
43 -> indirect                       82. (16., 1.7e+02)    
44 -> network                        0.26 (-5.0, 5.3)      
[2025-01-08 16:47:04]Saved diagnosis1 plot: 20250104-Consistency-serious-hypertension.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 73
   Unobserved stochastic nodes: 73
   Total graph size: 1359

[1] "serious-hypertension[2025-01-08 16:47:04]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                    t1                       t2  i2.pair   i2.cons   incons.p
1             Afatinib            Afatinib_Cetuximab       NA        NA         NA
2             Afatinib                Erlotinib       NA 34.144699 0.25001789
3             Afatinib                Gefitinib       NA 31.487579 0.11062263
4             Afatinib                  Placebo       NA 45.934623 0.04712181
5         Chemotherapy                Erlotinib  0.00000  0.000000         NA
6          Dacomitinib                Gefitinib       NA        NA         NA
7      Erlotinib_antiangio                    antiangio       NA  1.908029 0.35369667
8            Erlotinib           Erlotinib_IGF_1Ri       NA        NA         NA
9            Erlotinib           Erlotinib_METi       NA        NA         NA
10           Erlotinib          Erlotinib_antiangio 30.09957 30.393897         NA
11           Erlotinib                  Placebo       NA 31.317428 0.29273524
12           Erlotinib                    antiangio 28.70953 69.482280 0.04216072
13 Gefitinib_Erlotinib              Osimertinib       NA        NA         NA
14           Gefitinib   Gefitinib_chemotherapy  0.00000  0.000000         NA
15           Gefitinib          Gefitinib_antiangio 35.69112 41.410583         NA
16           Gefitinib               Lazertinib       NA 44.060098 0.06639974
17           Gefitinib                  Placebo       NA 41.960330 0.28467179
18           Gefitinib                    antiangio       NA  0.000000 0.43987820
19          Lazertinib              Osimertinib       NA 43.849590 0.08743303
20         Osimertinib Osimertinib_chemotherapy       NA        NA         NA
21         Osimertinib        Osimertinib_antiangio 66.54103 68.632813         NA
22         Osimertinib                  Placebo       NA 43.685303 0.55398311

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 58.59686 49.28818
[2025-01-08 16:47:04]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-hypertension.pdf
[1] "[2025-01-08 16:55:21]############################total-arrhythmias######################################"
Compiling model graph                                                                                                                                                               
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 111
   Unobserved stochastic nodes: 142
   Total graph size: 3270

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 16:55:21]Saved forest plot: 20250104-gemtc-forest-total-arrhythmias.pdf
[2025-01-08 16:55:21]Saved trace/density plot: 20250104-trace_density-total-arrhythmias.pdf
[2025-01-08 16:55:21]Saved diagnosis plot: 20250104-gelman.plot-total-arrhythmias.pdf
[1] "total-arrhythmias[2025-01-08 16:55:21]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Afatinib_HMGCRi                   1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Erlotinib_chemotherapy        1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.00       1.00
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_HGFi                   1.02       1.06
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.00       1.00
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Rociletinib                      1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib_Erlotinib.Zorifertinib           1.00       1.00
d.Gefitinib.Almonertinib                     1.00       1.00
d.Gefitinib.Furmonertinib                    1.00       1.00
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Chemotherapy_antiangio             1.17       1.45
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Lazertinib                     1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
d.Osimertinib.PD_L1i                         1.08       1.17
d.Osimertinib.Placebo                        1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.1
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 111
   Unobserved stochastic nodes: 143
   Total graph size: 5330

[1] "total-arrhythmias[2025-01-08 16:55:21]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                            p.value  CrI               
1  d.Afatinib.Chemotherapy               0.019400                   
2  -> direct                                      18. (0.87, 51.)   
3  -> indirect                                    -0.40 (-2.0, 1.6) 
4  -> network                                     0.068 (-1.5, 2.3) 
5  d.Afatinib.Erlotinib                  0.098375                   
6  -> direct                                      -1.0 (-3.0, 0.92) 
7  -> indirect                                    1.3 (-0.86, 4.1)  
8  -> network                                     -0.21 (-1.6, 1.5) 
9  d.Afatinib.Gefitinib                  0.014025                   
10 -> direct                                      25. (1.1, 65.)    
11 -> indirect                                    -1.1 (-3.3, 1.5)  
12 -> network                                     -0.37 (-2.5, 2.3) 
13 d.Afatinib.Placebo                    0.989900                   
14 -> direct                                      -1.2 (-5.0, 1.3)  
15 -> indirect                                    -1.3 (-3.4, 1.1)  
16 -> network                                     -1.2 (-3.0, 0.39) 
17 d.Chemotherapy.Erlotinib              0.815475                   
18 -> direct                                      -0.45 (-2.7, 0.86)
19 -> indirect                                    -0.15 (-3.6, 2.2) 
20 -> network                                     -0.25 (-1.6, 0.69)
21 d.Chemotherapy.Erlotinib_chemotherapy 0.829275                   
22 -> direct                                      -0.089 (-4.0, 4.0)
23 -> indirect                                    0.42 (-2.6, 2.8)  
24 -> network                                     0.45 (-1.6, 2.3)  
25 d.Chemotherapy.Gefitinib              0.891975                   
26 -> direct                                      -0.55 (-3.2, 1.6) 
27 -> indirect                                    -0.32 (-3.1, 2.6) 
28 -> network                                     -0.44 (-2.2, 1.3) 
29 d.Chemotherapy.Osimertinib            0.213050                   
30 -> direct                                      1.1 (-1.2, 3.8)   
31 -> indirect                                    -0.91 (-4.4, 1.3) 
32 -> network                                     0.25 (-1.6, 1.6)  
33 d.Dacomitinib.Erlotinib               0.521250                   
34 -> direct                                      0.63 (-1.3, 2.5)  
35 -> indirect                                    2.0 (-2.2, 6.6)   
36 -> network                                     0.75 (-0.57, 2.4) 
37 d.Dacomitinib.Placebo                 0.489725                   
38 -> direct                                      0.82 (-3.1, 4.6)  
39 -> indirect                                    -0.59 (-3.5, 1.5) 
40 -> network                                     -0.24 (-2.1, 1.5) 
41 d.Erlotinib.Placebo                   0.318275                   
42 -> direct                                      -2.1 (-5.7, 0.11) 
43 -> indirect                                    -0.59 (-2.7, 1.2) 
44 -> network                                     -1.0 (-2.6, 0.17) 
45 d.Erlotinib.antiangio                     0.002600                   
46 -> direct                                      1.6 (0.34, 3.4)   
47 -> indirect                                    21. (4.2, 38.)    
48 -> network                                     2.3 (1.0, 4.4)    
49 d.Erlotinib_antiangio.antiangio               0.051825                   
50 -> direct                                      18. (2.3, 45.)    
51 -> indirect                                    2.2 (0.67, 4.3)   
52 -> network                                     2.6 (1.2, 4.9)    
53 d.Gefitinib.Lazertinib                0.004750                   
54 -> direct                                      -30. (-85., -1.9) 
55 -> indirect                                    3.1 (-0.61, 7.3)  
56 -> network                                     0.87 (-2.3, 3.9)  
57 d.Gefitinib.antiangio                     0.005525                   
58 -> direct                                      18. (3.7, 55.)    
59 -> indirect                                    0.83 (-1.7, 3.3)  
60 -> network                                     2.4 (0.77, 4.6)   
61 d.Lazertinib.Osimertinib              0.002175                   
62 -> direct                                      -1.7 (-5.8, 1.2)  
63 -> indirect                                    49. (3.0, 1.3e+02)
64 -> network                                     -0.25 (-2.8, 2.4) 
65 d.Osimertinib.Placebo                 0.704700                   
66 -> direct                                      -1.4 (-3.7, 0.28) 
67 -> indirect                                    -2.0 (-5.6, 0.66) 
68 -> network                                     -1.5 (-3.1, -0.37)
[2025-01-08 16:55:21]Saved diagnosis1 plot: 20250104-Consistency-total-arrhythmias.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 111
   Unobserved stochastic nodes: 111
   Total graph size: 2053

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 111
   Unobserved stochastic nodes: 152
   Total graph size: 2266

[1] "total-arrhythmias[2025-01-08 16:55:21]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair  i2.cons     incons.p
1                Afatinib            Afatinib_Cetuximab       NA       NA           NA
2                Afatinib          Afatinib_HMGCRi       NA       NA           NA
3                Afatinib             Chemotherapy       NA 52.42071 0.3557229312
4                Afatinib                Erlotinib       NA 92.54716 0.0003677692
5                Afatinib                Gefitinib       NA 44.85178 0.2908781269
6                Afatinib                  Placebo       NA  0.00000 0.9481140218
7            Almonertinib                Gefitinib       NA       NA           NA
8  Amivantamab_Lazertinib               Lazertinib       NA       NA           NA
9  Amivantamab_Lazertinib              Osimertinib       NA       NA           NA
10     Chemotherapy_antiangio              Osimertinib       NA       NA           NA
11           Chemotherapy                Erlotinib  0.00000 10.93110           NA
12           Chemotherapy   Erlotinib_chemotherapy       NA  0.00000 0.8140423929
13           Chemotherapy                Gefitinib 46.31161  0.00000 0.9367813451
14           Chemotherapy              Osimertinib       NA 64.08576 0.1183866525
15            Dacomitinib                Erlotinib       NA       NA           NA
16            Dacomitinib                  Placebo       NA  0.00000 0.5811490525
17                  DHFRi                Erlotinib       NA       NA           NA
18        Erlotinib_antiangio                    antiangio       NA  0.00000 0.1380084069
19              Erlotinib     Erlotinib_Autophagyi       NA       NA           NA
20              Erlotinib   Erlotinib_chemotherapy  0.00000  0.00000           NA
21              Erlotinib          Erlotinib_HER3i       NA       NA           NA
22              Erlotinib           Erlotinib_HGFi       NA       NA           NA
23              Erlotinib           Erlotinib_IGF_1Ri 46.14056 51.49637           NA
24              Erlotinib           Erlotinib_METi  0.00000  0.00000           NA
25              Erlotinib           Erlotinib_MMPi       NA       NA           NA
26              Erlotinib          Erlotinib_antiangio  0.00000  0.00000           NA
27              Erlotinib                  Placebo 53.60693 20.58043 0.4432606758
28              Erlotinib              Rociletinib       NA       NA           NA
29              Erlotinib                    antiangio 44.23452 82.35582           NA
30          Furmonertinib                Gefitinib       NA       NA           NA
31    Gefitinib_Erlotinib              Osimertinib       NA       NA           NA
32    Gefitinib_Erlotinib             Zorifertinib       NA       NA           NA
33              Gefitinib   Gefitinib_chemotherapy 32.66950 36.17524           NA
34              Gefitinib               Lazertinib       NA 45.55755 0.0202397035
35              Gefitinib                    antiangio       NA 56.13446 0.1690018462
36             Lazertinib              Osimertinib       NA  0.00000 0.4269269547
37            Osimertinib Osimertinib_chemotherapy 50.42905 60.92907           NA
38            Osimertinib        Osimertinib_antiangio  0.00000  0.00000           NA
39            Osimertinib                   PD_L1i       NA       NA           NA
40            Osimertinib                  Placebo 37.47857 42.66850           NA

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 34.07442 25.45595
[2025-01-08 16:55:21]Saved diagnosis1 plot: 20250104-Heterogeneity-total-arrhythmias.pdf
[1] "[2025-01-08 17:12:46]############################total-heart failure######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 74
   Unobserved stochastic nodes: 97
   Total graph size: 2076

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 17:12:46]Saved forest plot: 20250104-gemtc-forest-total-heart failure.pdf
[2025-01-08 17:12:46]Saved trace/density plot: 20250104-trace_density-total-heart failure.pdf
[2025-01-08 17:12:46]Saved diagnosis plot: 20250104-gelman.plot-total-heart failure.pdf
[1] "total-heart failure[2025-01-08 17:12:46]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.Erlotinib_chemotherapy           1.00       1.00
d.Erlotinib.Erlotinib_HER3i                  1.00       1.01
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.02       1.05
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.antiangio                            1.01       1.02
d.Gefitinib.Almonertinib                     1.01       1.03
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_PARPi                  1.01       1.02
d.Gefitinib.Icotinib                         1.01       1.03
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.03
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 74
   Unobserved stochastic nodes: 98
   Total graph size: 3243

[1] "total-heart failure[2025-01-08 17:12:46]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                 p.value  CrI               
1  d.Afatinib.Chemotherapy    0.030500                   
2  -> direct                           16. (0.82, 51.)   
3  -> indirect                         -1.1 (-6.0, 3.7)  
4  -> network                          0.79 (-2.7, 5.3)  
5  d.Afatinib.Erlotinib       0.509350                   
6  -> direct                           0.34 (-3.4, 4.0)  
7  -> indirect                         2.3 (-2.2, 8.2)   
8  -> network                          0.89 (-1.6, 4.0)  
9  d.Afatinib.Placebo         0.717500                   
10 -> direct                           -1.1 (-5.6, 2.9)  
11 -> indirect                         -0.024 (-5.0, 4.5)
12 -> network                          -0.64 (-3.6, 2.2) 
13 d.Chemotherapy.Erlotinib   0.033475                   
14 -> direct                           -20. (-74., 0.12) 
15 -> indirect                         2.2 (-2.5, 7.8)   
16 -> network                          0.13 (-4.0, 3.8)  
17 d.Chemotherapy.Gefitinib   0.005800                   
18 -> direct                           14. (-0.40, 50.)  
19 -> indirect                         -16. (-52., -0.30)
20 -> network                          0.23 (-4.6, 6.2)  
21 d.Chemotherapy.Osimertinib 0.030500                   
22 -> direct                           16. (0.48, 55.)   
23 -> indirect                         -1.7 (-7.3, 3.4)  
24 -> network                          0.54 (-2.6, 4.7)  
25 d.Erlotinib.Placebo        0.008500                   
26 -> direct                           -27. (-75., -2.5) 
27 -> indirect                         1.1 (-3.1, 6.4)   
28 -> network                          -1.5 (-4.9, 1.1)  
29 d.Erlotinib_antiangio.antiangio    0.865600                   
30 -> direct                           15. (-0.33, 39.)  
31 -> indirect                         17. (1.2, 57.)    
32 -> network                          14. (1.9, 35.)    
33 d.Gefitinib.Lazertinib     0.002925                   
34 -> direct                           19. (0.039, 58.)  
35 -> indirect                         -22. (-54., -1.2) 
36 -> network                          0.084 (-4.6, 5.7) 
37 d.Lazertinib.Osimertinib   0.003875                   
38 -> direct                           1.2 (-2.2, 5.3)   
39 -> indirect                         -36. (-77., -5.8) 
40 -> network                          0.17 (-3.6, 3.6)  
41 d.Osimertinib.Placebo      0.000000                   
42 -> direct                           -0.74 (-3.4, 1.2) 
43 -> indirect                         -43. (-74., -20.) 
44 -> network                          -2.0 (-5.9, 0.11) 
[2025-01-08 17:12:46]Saved diagnosis1 plot: 20250104-Consistency-total-heart failure.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 74
   Unobserved stochastic nodes: 74
   Total graph size: 1368

[1] "total-heart failure[2025-01-08 17:12:46]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2   i2.pair   i2.cons  incons.p
1                Afatinib             Chemotherapy        NA 35.350480 0.1977740
2                Afatinib                Erlotinib        NA  0.000000 0.9134288
3                Afatinib                  Placebo        NA  0.000000 0.9072148
4            Almonertinib                Gefitinib        NA        NA        NA
5  Amivantamab_Lazertinib               Lazertinib        NA        NA        NA
6  Amivantamab_Lazertinib              Osimertinib        NA        NA        NA
7            Chemotherapy                Erlotinib        NA 42.405242 0.4239737
8            Chemotherapy                Gefitinib        NA 34.122422 0.1743343
9            Chemotherapy              Osimertinib        NA 35.385960 0.1510311
10            Dacomitinib                Erlotinib        NA        NA        NA
11        Erlotinib_antiangio                    antiangio        NA  0.000000 0.6045397
12              Erlotinib   Erlotinib_chemotherapy        NA        NA        NA
13              Erlotinib          Erlotinib_HER3i        NA        NA        NA
14              Erlotinib           Erlotinib_IGF_1Ri        NA        NA        NA
15              Erlotinib           Erlotinib_METi  0.000000  0.000000        NA
16              Erlotinib           Erlotinib_MMPi        NA        NA        NA
17              Erlotinib          Erlotinib_antiangio  8.845564  9.372433        NA
18              Erlotinib                  Placebo 84.319812 35.678851 0.1690951
19              Erlotinib                    antiangio 37.510918  0.000000        NA
20    Gefitinib_Erlotinib              Osimertinib        NA        NA        NA
21              Gefitinib   Gefitinib_chemotherapy 71.332965 71.384223        NA
22              Gefitinib          Gefitinib_PARPi        NA        NA        NA
23              Gefitinib                 Icotinib        NA        NA        NA
24              Gefitinib               Lazertinib        NA 34.336606 0.4226791
25             Lazertinib              Osimertinib        NA  0.000000 0.8089326
26            Osimertinib Osimertinib_chemotherapy        NA        NA        NA
27            Osimertinib        Osimertinib_antiangio        NA        NA        NA
28            Osimertinib                  Placebo 57.135756 83.882401 0.8133603

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 90.75675 51.83622
[2025-01-08 17:12:46]Saved diagnosis1 plot: 20250104-Heterogeneity-total-heart failure.pdf
[1] "[2025-01-08 17:21:19]############################total-Vascular Toxicity######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 148
   Unobserved stochastic nodes: 178
   Total graph size: 3946

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 17:21:19]Saved forest plot: 20250104-gemtc-forest-total-Vascular Toxicity.pdf
[2025-01-08 17:21:19]Saved trace/density plot: 20250104-trace_density-total-Vascular Toxicity.pdf
[2025-01-08 17:21:19]Saved diagnosis plot: 20250104-gelman.plot-total-Vascular Toxicity.pdf
[1] "total-Vascular Toxicity[2025-01-08 17:21:19]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Placebo                           1.00       1.00
d.Chemotherapy.Afatinib                      1.00       1.00
d.Chemotherapy.Erlotinib                     1.00       1.00
d.Chemotherapy.Gefitinib                     1.00       1.00
d.Chemotherapy.Osimertinib                   1.00       1.00
d.Erlotinib.Dacomitinib                      1.00       1.00
d.Erlotinib.DHFRi                            1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.02       1.03
d.Erlotinib.Erlotinib_chemotherapy           1.00       1.00
d.Erlotinib.Erlotinib_COX2i                  1.02       1.05
d.Erlotinib.Erlotinib_ERi                    1.00       1.00
d.Erlotinib.Erlotinib_HER3i                  1.00       1.00
d.Erlotinib.Erlotinib_HGFi                   1.00       1.00
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.00       1.00
d.Erlotinib.Erlotinib_MMPi                   1.00       1.00
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.Gefitinib_ERi                    1.00       1.00
d.Erlotinib.Rociletinib                      1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib.Almonertinib                     1.06       1.15
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
d.Osimertinib.PD_L1i                         1.00       1.00
sd.d                                         1.00       1.01

Multivariate psrf

1.05
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 148
   Unobserved stochastic nodes: 179
   Total graph size: 5881

[1] "total-Vascular Toxicity[2025-01-08 17:21:19]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                 p.value  CrI                 
1  d.Afatinib.Chemotherapy    0.441225                     
2  -> direct                           0.58 (-0.94, 2.2)   
3  -> indirect                         -0.10 (-1.1, 0.89)  
4  -> network                          0.10 (-0.68, 0.93)  
5  d.Afatinib.Erlotinib       0.626050                     
6  -> direct                           -0.017 (-1.2, 1.2)  
7  -> indirect                         -0.36 (-1.3, 0.72)  
8  -> network                          -0.19 (-0.91, 0.57) 
9  d.Afatinib.Gefitinib       0.753575                     
10 -> direct                           -0.68 (-2.0, 0.62)  
11 -> indirect                         -0.41 (-1.5, 0.61)  
12 -> network                          -0.53 (-1.4, 0.26)  
13 d.Afatinib.Placebo         0.225725                     
14 -> direct                           -1.3 (-3.5, 0.29)   
15 -> indirect                         -0.18 (-1.2, 0.78)  
16 -> network                          -0.45 (-1.3, 0.35)  
17 d.Chemotherapy.Erlotinib   0.032325                     
18 -> direct                           0.20 (-0.57, 1.1)   
19 -> indirect                         -1.2 (-2.3, -0.15)  
20 -> network                          -0.29 (-0.92, 0.35) 
21 d.Chemotherapy.Gefitinib   0.173050                     
22 -> direct                           -1.3 (-2.8, -0.095) 
23 -> indirect                         -0.24 (-1.2, 0.77)  
24 -> network                          -0.62 (-1.4, 0.079) 
25 d.Chemotherapy.Osimertinib 0.600575                     
26 -> direct                           -0.36 (-1.7, 1.0)   
27 -> indirect                         0.097 (-1.2, 1.3)   
28 -> network                          -0.10 (-1.0, 0.79)  
29 d.Dacomitinib.Erlotinib    0.257375                     
30 -> direct                           0.56 (-0.49, 1.7)   
31 -> indirect                         -0.43 (-1.9, 0.99)  
32 -> network                          0.19 (-0.62, 1.1)   
33 d.Dacomitinib.Gefitinib    0.563550                     
34 -> direct                           -0.88 (-4.4, 1.7)   
35 -> indirect                         -0.030 (-1.1, 1.1)  
36 -> network                          -0.14 (-1.2, 0.86)  
37 d.Dacomitinib.Placebo      0.362000                     
38 -> direct                           -0.58 (-2.1, 0.81)  
39 -> indirect                         0.24 (-0.95, 1.4)   
40 -> network                          -0.066 (-0.98, 0.81)
41 d.Erlotinib.Gefitinib      0.232025                     
42 -> direct                           0.45 (-1.1, 2.1)    
43 -> indirect                         -0.56 (-1.5, 0.19)  
44 -> network                          -0.34 (-1.1, 0.36)  
45 d.Erlotinib.Placebo        0.009100                     
46 -> direct                           0.39 (-0.37, 1.1)   
47 -> indirect                         -1.1 (-2.0, -0.28)  
48 -> network                          -0.27 (-0.96, 0.34) 
49 d.Erlotinib_antiangio.antiangio    0.187575                     
50 -> direct                           1.5 (-0.25, 3.7)    
51 -> indirect                         0.085 (-1.0, 1.3)   
52 -> network                          0.52 (-0.38, 1.6)   
53 d.Gefitinib.Lazertinib     0.819375                     
54 -> direct                           0.93 (-0.31, 2.2)   
55 -> indirect                         0.70 (-0.88, 2.4)   
56 -> network                          0.86 (-0.069, 1.8)  
57 d.Gefitinib.Placebo        0.234275                     
58 -> direct                           -0.79 (-2.6, 0.85)  
59 -> indirect                         0.34 (-0.56, 1.3)   
60 -> network                          0.080 (-0.71, 0.86) 
61 d.Lazertinib.Osimertinib   0.827150                     
62 -> direct                           -0.27 (-1.4, 0.82)  
63 -> indirect                         -0.48 (-2.2, 1.2)   
64 -> network                          -0.33 (-1.2, 0.56)  
65 d.Osimertinib.Placebo      0.728500                     
66 -> direct                           -0.65 (-2.0, 0.70)  
67 -> indirect                         -0.34 (-1.7, 0.93)  
68 -> network                          -0.45 (-1.4, 0.44)  
[2025-01-08 17:21:19]Saved diagnosis1 plot: 20250104-Consistency-total-Vascular Toxicity.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 148
   Unobserved stochastic nodes: 148
   Total graph size: 2728

[1] "total-Vascular Toxicity[2025-01-08 17:21:19]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair   i2.cons   incons.p
1                Afatinib            Afatinib_Cetuximab       NA        NA         NA
2                Afatinib             Chemotherapy 52.59383  4.823848 0.42973882
3                Afatinib                Erlotinib       NA  0.000000 0.77409610
4                Afatinib                Gefitinib       NA  0.000000 0.81907381
5                Afatinib                  Placebo       NA 28.895329 0.35157747
6            Almonertinib                Gefitinib       NA        NA         NA
7  Amivantamab_Lazertinib               Lazertinib       NA        NA         NA
8  Amivantamab_Lazertinib              Osimertinib       NA        NA         NA
9            Chemotherapy                Erlotinib 47.41628 38.415426 0.14652104
10           Chemotherapy                Gefitinib 59.96287 37.160403 0.22655421
11           Chemotherapy              Osimertinib       NA  0.000000 0.66640069
12            Dacomitinib                Erlotinib 13.32034  0.000000 0.43507784
13            Dacomitinib                Gefitinib       NA  0.000000 0.65204007
14            Dacomitinib                  Placebo       NA  0.000000 0.47566408
15                  DHFRi                Erlotinib       NA        NA         NA
16          Erlotinib_ERi                Gefitinib       NA        NA         NA
17          Erlotinib_ERi            Gefitinib_ERi       NA        NA         NA
18        Erlotinib_antiangio                    antiangio       NA 20.226662 0.34320150
19              Erlotinib     Erlotinib_Autophagyi       NA        NA         NA
20              Erlotinib   Erlotinib_chemotherapy 46.36428 42.859192         NA
21              Erlotinib          Erlotinib_COX2i       NA        NA         NA
22              Erlotinib            Erlotinib_ERi       NA        NA         NA
23              Erlotinib          Erlotinib_HER3i       NA        NA         NA
24              Erlotinib           Erlotinib_HGFi       NA        NA         NA
25              Erlotinib           Erlotinib_IGF_1Ri 53.93836 50.491657         NA
26              Erlotinib           Erlotinib_METi  0.00000  0.000000         NA
27              Erlotinib           Erlotinib_MMPi       NA        NA         NA
28              Erlotinib          Erlotinib_antiangio 30.47789 30.553990         NA
29              Erlotinib                Gefitinib       NA  0.000000 0.54245684
30              Erlotinib            Gefitinib_ERi       NA        NA         NA
31              Erlotinib                  Placebo  9.73290 60.968156 0.07345984
32              Erlotinib              Rociletinib       NA        NA         NA
33              Erlotinib                    antiangio 37.36546 51.210117         NA
34    Gefitinib_Erlotinib              Osimertinib       NA        NA         NA
35              Gefitinib   Gefitinib_chemotherapy 44.48806 42.873327         NA
36              Gefitinib            Gefitinib_ERi       NA        NA         NA
37              Gefitinib               Lazertinib       NA  0.000000 0.88326008
38              Gefitinib                  Placebo 43.88261 22.887808 0.28723109
39             Lazertinib              Osimertinib       NA  0.000000 0.92898513
40            Osimertinib Osimertinib_chemotherapy       NA        NA         NA
41            Osimertinib        Osimertinib_antiangio       NA        NA         NA
42            Osimertinib                   PD_L1i       NA        NA         NA
43            Osimertinib                  Placebo  0.00000  0.000000 0.85001635

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 37.93403 24.10891
[2025-01-08 17:21:19]Saved diagnosis1 plot: 20250104-Heterogeneity-total-Vascular Toxicity.pdf
[1] "[2025-01-08 17:42:37]############################total-hypertension######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 94
   Unobserved stochastic nodes: 116
   Total graph size: 2452

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 17:42:37]Saved forest plot: 20250104-gemtc-forest-total-hypertension.pdf
[2025-01-08 17:42:37]Saved trace/density plot: 20250104-trace_density-total-hypertension.pdf
[2025-01-08 17:42:37]Saved diagnosis plot: 20250104-gelman.plot-total-hypertension.pdf
[1] "total-hypertension[2025-01-08 17:42:37]: gelman.diag"
Potential scale reduction factors:

                                       Point est. Upper C.I.
d.Afatinib.Afatinib_Cetuximab                     1.00       1.00
d.Afatinib.Chemotherapy                      1.00       1.00
d.Erlotinib.Erlotinib_Autophagyi             1.00       1.00
d.Erlotinib.Erlotinib_IGF_1Ri                   1.00       1.00
d.Erlotinib.Erlotinib_METi                   1.11       1.30
d.Erlotinib.Erlotinib_antiangio                  1.00       1.00
d.Erlotinib.antiangio                            1.00       1.00
d.Gefitinib.Almonertinib                     1.00       1.00
d.Gefitinib.Dacomitinib                      1.00       1.00
d.Gefitinib.Gefitinib_chemotherapy           1.00       1.00
d.Gefitinib.Gefitinib_antiangio                  1.00       1.00
d.Gefitinib.Lazertinib                       1.00       1.00
d.Osimertinib.Amivantamab_Lazertinib         1.00       1.00
d.Osimertinib.Gefitinib_Erlotinib            1.00       1.00
d.Osimertinib.Osimertinib_chemotherapy       1.00       1.00
d.Osimertinib.Osimertinib_antiangio              1.00       1.00
d.Osimertinib.PD_L1i                         1.02       1.04
d.Placebo.Afatinib                           1.00       1.00
d.Placebo.Erlotinib                          1.00       1.00
d.Placebo.Gefitinib                          1.00       1.00
d.Placebo.Osimertinib                        1.00       1.00
sd.d                                         1.00       1.00

Multivariate psrf

1.08
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 94
   Unobserved stochastic nodes: 117
   Total graph size: 3524

[1] "total-hypertension[2025-01-08 17:42:37]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                 p.value  CrI                  
1  d.Afatinib.Chemotherapy    0.270225                      
2  -> direct                           0.80 (-0.73, 2.3)    
3  -> indirect                         2.8 (-0.39, 6.7)     
4  -> network                          1.1 (-0.15, 2.5)     
5  d.Afatinib.Erlotinib       0.008875                      
6  -> direct                           43. (3.0, 95.)       
7  -> indirect                         -0.62 (-2.8, 1.2)    
8  -> network                          -0.18 (-1.9, 1.6)    
9  d.Afatinib.Gefitinib       0.007700                      
10 -> direct                           26. (3.3, 77.)       
11 -> indirect                         -0.46 (-2.8, 1.7)    
12 -> network                          0.032 (-2.0, 2.0)    
13 d.Afatinib.Placebo         0.025050                      
14 -> direct                           -48. (-1.6e+02, -1.5)
15 -> indirect                         0.38 (-1.8, 2.6)     
16 -> network                          -0.062 (-2.0, 1.9)   
17 d.Chemotherapy.Erlotinib   0.138625                      
18 -> direct                           -2.5 (-6.1, -0.31)   
19 -> indirect                         -0.053 (-2.4, 2.4)   
20 -> network                          -1.2 (-2.8, 0.19)    
21 d.Chemotherapy.Osimertinib 0.616375                      
22 -> direct                           -0.88 (-2.5, 0.71)   
23 -> indirect                         -1.7 (-4.7, 1.3)     
24 -> network                          -1.0 (-2.4, 0.33)    
25 d.Erlotinib.Placebo        0.566075                      
26 -> direct                           0.26 (-1.2, 1.7)     
27 -> indirect                         -0.74 (-4.7, 2.5)    
28 -> network                          0.13 (-1.2, 1.3)     
29 d.Erlotinib.antiangio          0.231250                      
30 -> direct                           2.3 (1.2, 3.4)       
31 -> indirect                         4.4 (1.1, 8.7)       
32 -> network                          2.3 (1.4, 3.3)       
33 d.Erlotinib_antiangio.antiangio    0.578675                      
34 -> direct                           0.15 (-1.5, 1.8)     
35 -> indirect                         0.71 (-0.71, 2.2)    
36 -> network                          0.49 (-0.49, 1.5)    
37 d.Gefitinib.Lazertinib     0.211575                      
38 -> direct                           -0.33 (-1.9, 1.2)    
39 -> indirect                         1.9 (-1.2, 5.3)      
40 -> network                          0.082 (-1.3, 1.5)    
41 d.Gefitinib.Placebo        0.019900                      
42 -> direct                           31. (1.2, 90.)       
43 -> indirect                         -0.66 (-2.9, 1.4)    
44 -> network                          -0.092 (-2.0, 1.8)   
45 d.Gefitinib.antiangio          0.189500                      
46 -> direct                           3.2 (0.93, 6.6)      
47 -> indirect                         0.92 (-1.8, 3.5)     
48 -> network                          2.1 (0.54, 3.8)      
49 d.Lazertinib.Osimertinib   0.201875                      
50 -> direct                           -0.44 (-1.9, 1.0)    
51 -> indirect                         1.8 (-1.3, 5.2)      
52 -> network                          -0.094 (-1.3, 1.3)   
53 d.Osimertinib.Placebo      0.009750                      
54 -> direct                           -65. (-1.5e+02, -3.3)
55 -> indirect                         0.42 (-1.8, 2.5)     
56 -> network                          -0.084 (-2.1, 1.8)   
[2025-01-08 17:42:37]Saved diagnosis1 plot: 20250104-Consistency-total-hypertension.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 94
   Unobserved stochastic nodes: 94
   Total graph size: 1760

Initializing model

[1] "total-hypertension[2025-01-08 17:42:37]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                       t1                       t2  i2.pair   i2.cons  incons.p
1                Afatinib            Afatinib_Cetuximab       NA        NA        NA
2                Afatinib             Chemotherapy       NA  4.258703 0.4141558
3                Afatinib                Erlotinib       NA 51.049065 0.2354378
4                Afatinib                Gefitinib       NA 52.317720 0.2151206
5                Afatinib                  Placebo       NA 41.887773 0.1010154
6            Almonertinib                Gefitinib       NA        NA        NA
7  Amivantamab_Lazertinib               Lazertinib       NA        NA        NA
8  Amivantamab_Lazertinib              Osimertinib       NA        NA        NA
9            Chemotherapy                Erlotinib 41.36999 21.136862 0.3445766
10           Chemotherapy              Osimertinib       NA  0.000000 0.6611575
11            Dacomitinib                Gefitinib       NA        NA        NA
12        Erlotinib_antiangio                    antiangio       NA  0.000000 0.6111493
13              Erlotinib     Erlotinib_Autophagyi       NA        NA        NA
14              Erlotinib           Erlotinib_IGF_1Ri       NA        NA        NA
15              Erlotinib           Erlotinib_METi       NA        NA        NA
16              Erlotinib          Erlotinib_antiangio 69.08387 69.640752        NA
17              Erlotinib                  Placebo       NA  0.000000 0.7047959
18              Erlotinib                    antiangio  0.00000  0.000000 0.8748072
19    Gefitinib_Erlotinib              Osimertinib       NA        NA        NA
20              Gefitinib   Gefitinib_chemotherapy  0.00000  0.000000        NA
21              Gefitinib          Gefitinib_antiangio 78.67336 77.560285        NA
22              Gefitinib               Lazertinib       NA 34.898730 0.3044976
23              Gefitinib                  Placebo       NA 35.971617 0.1039285
24              Gefitinib                    antiangio       NA 14.929260 0.3861072
25             Lazertinib              Osimertinib       NA  0.000000 0.4363865
26            Osimertinib Osimertinib_chemotherapy 49.83853 50.645081        NA
27            Osimertinib        Osimertinib_antiangio 39.94125 39.612467        NA
28            Osimertinib                   PD_L1i       NA        NA        NA
29            Osimertinib                  Placebo       NA 42.808453 0.1695442

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 59.82595 55.29101
[2025-01-08 17:42:37]Saved diagnosis1 plot: 20250104-Heterogeneity-total-hypertension.pdf
[1] "[2025-01-08 17:54:26]############################serious-arrhythmias-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 90
   Unobserved stochastic nodes: 109
   Total graph size: 2217

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 17:54:26]Saved forest plot: 20250104-gemtc-forest-serious-arrhythmias-gen.pdf
[2025-01-08 17:54:26]Saved trace/density plot: 20250104-trace_density-serious-arrhythmias-gen.pdf
[2025-01-08 17:54:26]Saved diagnosis plot: 20250104-gelman.plot-serious-arrhythmias-gen.pdf
[1] "serious-arrhythmias-gen[2025-01-08 17:54:26]: gelman.diag"
Potential scale reduction factors:

                              Point est. Upper C.I.
d.Chemotherapy.I                    1.00       1.00
d.Chemotherapy.I_chemotherapy       1.00       1.00
d.Chemotherapy.II                   1.00       1.00
d.Chemotherapy.III                  1.00       1.00
d.Gef_Erl.Zorifertinib              1.00       1.00
d.I.DHFRi                           1.00       1.00
d.I.I_HER3i                         1.00       1.00
d.I.I_IGF_1Ri                          1.00       1.00
d.I.I_METi                          1.00       1.00
d.I.I_antiangio                         1.00       1.00
d.I.Rociletinib                     1.00       1.00
d.I.antiangio                           1.00       1.00
d.II.II_Cetuximab                        1.02       1.05
d.II.II_HMGCRi                      1.06       1.16
d.III.Gef_Erl                       1.00       1.00
d.III.III_chemotherapy              1.00       1.00
d.III.III_antiangio                     1.10       1.25
d.III.Placebo                       1.00       1.00
sd.d                                1.00       1.00

Multivariate psrf

1.07
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 89
   Unobserved stochastic nodes: 109
   Total graph size: 3010

[1] "serious-arrhythmias-gen[2025-01-08 17:54:26]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                    p.value  CrI                  
1  d.Chemotherapy.I              0.909250                      
2  -> direct                              -0.44 (-2.1, 0.89)   
3  -> indirect                            -0.62 (-3.4, 2.2)    
4  -> network                             -0.44 (-1.7, 0.70)   
5  d.Chemotherapy.I_chemotherapy 0.780375                      
6  -> direct                              -0.081 (-4.3, 3.8)   
7  -> indirect                            0.58 (-2.9, 4.5)     
8  -> network                             0.53 (-2.0, 3.1)     
9  d.Chemotherapy.II             0.021575                      
10 -> direct                              -47. (-1.4e+02, -2.3)
11 -> indirect                            -0.34 (-2.3, 1.2)    
12 -> network                             -0.66 (-2.7, 0.80)   
13 d.Chemotherapy.III            0.524500                      
14 -> direct                              0.66 (-2.3, 4.7)     
15 -> indirect                            -0.40 (-2.8, 1.4)    
16 -> network                             -0.15 (-1.8, 1.3)    
17 d.I.II                        0.232550                      
18 -> direct                              0.15 (-1.5, 1.4)     
19 -> indirect                            -1.4 (-4.5, 0.89)    
20 -> network                             -0.19 (-1.7, 0.84)   
21 d.I.III                       0.741250                      
22 -> direct                              0.18 (-1.7, 1.8)     
23 -> indirect                            0.59 (-1.5, 3.0)     
24 -> network                             0.31 (-0.90, 1.6)    
25 d.I.Placebo                   0.406700                      
26 -> direct                              -2.0 (-5.4, 0.13)    
27 -> indirect                            -0.79 (-2.9, 0.92)   
28 -> network                             -1.2 (-2.8, 0.080)   
29 d.I_antiangio.antiangio               0.034250                      
30 -> direct                              35. (3.1, 86.)       
31 -> indirect                            1.9 (-0.23, 4.3)     
32 -> network                             2.2 (0.46, 4.5)      
33 d.II.Placebo                  0.508525                      
34 -> direct                              -0.46 (-2.9, 1.6)    
35 -> indirect                            -1.5 (-3.8, 0.74)    
36 -> network                             -0.96 (-2.5, 0.54)   
37 d.III.Placebo                 0.889100                      
38 -> direct                              -1.4 (-4.2, 0.64)    
39 -> indirect                            -1.7 (-4.3, 0.44)    
40 -> network                             -1.5 (-3.3, -0.14)   
[2025-01-08 17:54:26]Saved diagnosis1 plot: 20250104-Consistency-serious-arrhythmias-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 90
   Unobserved stochastic nodes: 90
   Total graph size: 1663

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 90
   Unobserved stochastic nodes: 115
   Total graph size: 1829

[1] "serious-arrhythmias-gen[2025-01-08 17:54:26]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2  i2.pair   i2.cons  incons.p
1  Chemotherapy                I 22.57914 11.017211 0.8700533
2  Chemotherapy   I_chemotherapy       NA  0.000000 0.7774038
3  Chemotherapy               II       NA 42.821402 0.2012170
4  Chemotherapy              III       NA  0.000000 0.6651759
5         DHFRi                I       NA        NA        NA
6       Gef_Erl              III       NA        NA        NA
7       Gef_Erl     Zorifertinib       NA        NA        NA
8       I_antiangio            antiangio       NA  0.000000 0.2934369
9             I   I_chemotherapy  0.00000  0.000000        NA
10            I          I_HER3i       NA        NA        NA
11            I           I_IGF_1Ri 59.06738 57.858444        NA
12            I           I_METi 14.34323 14.534943        NA
13            I          I_antiangio 13.44477  1.416751        NA
14            I               II 56.75668 47.291405 0.7032154
15            I              III 11.57317  0.000000 0.7968356
16            I          Placebo 56.35316 19.805477 0.5036673
17            I      Rociletinib       NA        NA        NA
18            I            antiangio 73.81911 74.279535        NA
19           II          II_Cetuximab       NA        NA        NA
20           II        II_HMGCRi       NA        NA        NA
21           II          Placebo  0.00000  0.000000 0.6661838
22          III III_chemotherapy       NA        NA        NA
23          III        III_antiangio  0.00000  0.000000        NA
24          III          Placebo 37.79604  0.000000 0.9950391

Global I-squared:
-------------------------

  i2.pair  i2.cons
1 45.1773 27.05324
[2025-01-08 17:54:26]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-arrhythmias-gen.pdf
[1] "[2025-01-08 18:03:46]############################serious-heart failure-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 62
   Unobserved stochastic nodes: 78
   Total graph size: 1541

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 18:03:46]Saved forest plot: 20250104-gemtc-forest-serious-heart failure-gen.pdf
[2025-01-08 18:03:46]Saved trace/density plot: 20250104-trace_density-serious-heart failure-gen.pdf
[2025-01-08 18:03:46]Saved diagnosis plot: 20250104-gelman.plot-serious-heart failure-gen.pdf
[1] "serious-heart failure-gen[2025-01-08 18:03:46]: gelman.diag"
Potential scale reduction factors:

                       Point est. Upper C.I.
d.I.Chemotherapy             1.00       1.00
d.I.I_chemotherapy           1.00       1.00
d.I.I_HER3i                  1.00       1.01
d.I.I_IGF_1Ri                   1.00       1.00
d.I.I_METi                   1.00       1.00
d.I.I_MMPi                   1.00       1.00
d.I.I_PARPi                  1.02       1.04
d.I.I_antiangio                  1.00       1.00
d.I.II                       1.00       1.00
d.I.III                      1.00       1.00
d.I.Placebo                  1.00       1.00
d.I.antiangio                    1.01       1.03
d.III.Gef_Erl                1.00       1.00
d.III.III_chemotherapy       1.01       1.01
d.III.III_antiangio              1.03       1.07
sd.d                         1.00       1.00

Multivariate psrf

1.02
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 62
   Unobserved stochastic nodes: 79
   Total graph size: 2134

[1] "serious-heart failure-gen[2025-01-08 18:03:46]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison         p.value  CrI                
1  d.Chemotherapy.I   0.803300                    
2  -> direct                   0.033 (-4.2, 4.4)  
3  -> indirect                 0.73 (-3.6, 5.1)   
4  -> network                  0.26 (-2.5, 3.2)   
5  d.Chemotherapy.II  0.022750                    
6  -> direct                   -21. (-79., -1.1)  
7  -> indirect                 1.0 (-2.5, 5.3)    
8  -> network                  -0.45 (-3.8, 2.6)  
9  d.Chemotherapy.III 0.024325                    
10 -> direct                   14. (0.011, 57.)   
11 -> indirect                 -2.4 (-7.1, 1.7)   
12 -> network                  -0.094 (-3.0, 3.2) 
13 d.I.II             0.363475                    
14 -> direct                   -0.21 (-2.8, 2.4)  
15 -> indirect                 -2.2 (-7.3, 1.5)   
16 -> network                  -0.71 (-3.1, 1.1)  
17 d.I.III            0.864350                    
18 -> direct                   -0.045 (-4.3, 4.3) 
19 -> indirect                 -0.49 (-4.0, 3.1)  
20 -> network                  -0.33 (-2.8, 2.3)  
21 d.I.Placebo        0.015200                    
22 -> direct                   -27. (-80., -2.5)  
23 -> indirect                 -0.42 (-3.5, 2.5)  
24 -> network                  -1.6 (-4.6, 0.58)  
25 d.II.Placebo       0.873550                    
26 -> direct                   -1.1 (-5.3, 2.6)   
27 -> indirect                 -0.70 (-5.1, 2.7)  
28 -> network                  -0.82 (-3.7, 1.6)  
29 d.III.Placebo      0.118600                    
30 -> direct                   -0.19 (-3.3, 2.4)  
31 -> indirect                 -4.1 (-10., -0.056)
32 -> network                  -1.2 (-4.3, 0.89)  
[2025-01-08 18:03:46]Saved diagnosis1 plot: 20250104-Consistency-serious-heart failure-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 62
   Unobserved stochastic nodes: 62
   Total graph size: 1149

[1] "serious-heart failure-gen[2025-01-08 18:03:46]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2  i2.pair  i2.cons   incons.p
1  Chemotherapy                I 68.54988 37.14766 0.83481407
2  Chemotherapy               II       NA 43.95182 0.30656718
3  Chemotherapy              III       NA 43.03756 0.30722572
4       Gef_Erl              III       NA       NA         NA
5             I   I_chemotherapy 57.00374 57.92024         NA
6             I          I_HER3i       NA       NA         NA
7             I           I_IGF_1Ri       NA       NA         NA
8             I           I_METi  0.00000  0.00000         NA
9             I           I_MMPi       NA       NA         NA
10            I          I_PARPi       NA       NA         NA
11            I          I_antiangio 33.28057 33.25199         NA
12            I               II  0.00000  0.00000 0.48799646
13            I              III 71.12590 42.83713 0.85310441
14            I          Placebo  0.00000 34.53049 0.09288206
15            I            antiangio       NA       NA         NA
16           II          Placebo       NA  0.00000 0.87159906
17          III III_chemotherapy       NA       NA         NA
18          III        III_antiangio       NA       NA         NA
19          III          Placebo 50.47834 69.17830 0.09023170

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 31.91546 43.38328
[2025-01-08 18:03:46]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-heart failure-gen.pdf
[1] "[2025-01-08 18:09:47]############################serious-Vascular Toxicity-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 139
   Unobserved stochastic nodes: 161
   Total graph size: 3317

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 18:09:47]Saved forest plot: 20250104-gemtc-forest-serious-Vascular Toxicity-gen.pdf
[2025-01-08 18:09:47]Saved trace/density plot: 20250104-trace_density-serious-Vascular Toxicity-gen.pdf
[2025-01-08 18:09:47]Saved diagnosis plot: 20250104-gelman.plot-serious-Vascular Toxicity-gen.pdf
[1] "serious-Vascular Toxicity-gen[2025-01-08 18:09:47]: gelman.diag"
Potential scale reduction factors:

                       Point est. Upper C.I.
d.Chemotherapy.I             1.00       1.00
d.Chemotherapy.II            1.00       1.00
d.Chemotherapy.III           1.00       1.00
d.I.DHFRi                    1.00       1.00
d.I.I_Autophagyi             1.03       1.06
d.I.I_chemotherapy           1.00       1.00
d.I.I_COX2i                  1.07       1.18
d.I.I_ERi                    1.05       1.14
d.I.I_HER3i                  1.00       1.00
d.I.I_HGFi                   1.02       1.04
d.I.I_IGF_1Ri                   1.00       1.00
d.I.I_METi                   1.00       1.00
d.I.I_MMPi                   1.00       1.00
d.I.I_antiangio                  1.00       1.00
d.I.Placebo                  1.00       1.00
d.I.Rociletinib              1.00       1.00
d.I.antiangio                    1.00       1.00
d.II.II_Cetuximab                 1.00       1.00
d.III.Gef_Erl                1.00       1.00
d.III.III_chemotherapy       1.00       1.00
d.III.III_antiangio              1.00       1.00
sd.d                         1.00       1.00

Multivariate psrf

1.07
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 139
   Unobserved stochastic nodes: 162
   Total graph size: 4392

[1] "serious-Vascular Toxicity-gen[2025-01-08 18:09:47]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison         p.value  CrI                  
1  d.Chemotherapy.I   0.065675                      
2  -> direct                   -0.16 (-0.92, 0.56)  
3  -> indirect                 -1.4 (-2.6, -0.30)   
4  -> network                  -0.51 (-1.2, 0.14)   
5  d.Chemotherapy.II  0.628675                      
6  -> direct                   -0.66 (-2.3, 0.92)   
7  -> indirect                 -0.23 (-1.2, 0.73)   
8  -> network                  -0.32 (-1.1, 0.46)   
9  d.Chemotherapy.III 0.045500                      
10 -> direct                   -0.32 (-1.7, 0.98)   
11 -> indirect                 1.3 (0.34, 2.4)      
12 -> network                  0.73 (-0.14, 1.7)    
13 d.I.II             0.332525                      
14 -> direct                   -0.0035 (-0.71, 0.68)
15 -> indirect                 0.60 (-0.47, 1.7)    
16 -> network                  0.18 (-0.41, 0.75)   
17 d.I.III            0.004650                      
18 -> direct                   2.1 (1.2, 3.3)       
19 -> indirect                 0.17 (-0.82, 1.1)    
20 -> network                  1.2 (0.50, 2.0)      
21 d.I.Placebo        0.623800                      
22 -> direct                   0.070 (-0.79, 0.86)  
23 -> indirect                 -0.26 (-1.3, 0.85)   
24 -> network                  -0.032 (-0.68, 0.58) 
25 d.I_antiangio.antiangio    0.352400                      
26 -> direct                   1.1 (-0.87, 3.4)     
27 -> indirect                 -0.0080 (-1.3, 1.4)  
28 -> network                  0.44 (-0.59, 1.7)    
29 d.II.Placebo       0.114200                      
30 -> direct                   -0.88 (-2.1, 0.22)   
31 -> indirect                 0.24 (-0.68, 1.2)    
32 -> network                  -0.21 (-0.96, 0.51)  
33 d.III.Placebo      0.229800                      
34 -> direct                   -0.57 (-2.1, 0.81)   
35 -> indirect                 -1.7 (-3.0, -0.62)   
36 -> network                  -1.3 (-2.2, -0.43)   
[2025-01-08 18:09:47]Saved diagnosis1 plot: 20250104-Consistency-serious-Vascular Toxicity-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 139
   Unobserved stochastic nodes: 139
   Total graph size: 2564

[1] "serious-Vascular Toxicity-gen[2025-01-08 18:09:47]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2   i2.pair   i2.cons     incons.p
1  Chemotherapy                I 46.245665 68.460779 6.543916e-05
2  Chemotherapy               II 50.789501  0.000000 6.428390e-01
3  Chemotherapy              III        NA 85.885037 1.774766e-02
4         DHFRi                I        NA        NA           NA
5       Gef_Erl              III        NA        NA           NA
6       I_antiangio            antiangio        NA  0.000000 4.571982e-01
7             I     I_Autophagyi        NA        NA           NA
8             I   I_chemotherapy 41.812996 44.392024           NA
9             I          I_COX2i        NA        NA           NA
10            I            I_ERi        NA        NA           NA
11            I          I_HER3i        NA        NA           NA
12            I           I_HGFi        NA        NA           NA
13            I           I_IGF_1Ri 54.719024 57.985348           NA
14            I           I_METi  0.000000  0.000000           NA
15            I           I_MMPi        NA        NA           NA
16            I          I_antiangio  1.382763  1.864123           NA
17            I               II 10.989808 35.546818 7.193480e-02
18            I              III 67.131973 60.443168 2.462032e-02
19            I          Placebo 20.323487 17.719874 3.808089e-01
20            I      Rociletinib        NA        NA           NA
21            I            antiangio 37.024119 67.383969           NA
22           II          II_Cetuximab        NA        NA           NA
23           II          Placebo  0.000000 43.263527 1.259366e-01
24          III III_chemotherapy        NA        NA           NA
25          III        III_antiangio        NA        NA           NA
26          III          Placebo  0.000000  0.000000 1.713290e-01

Global I-squared:
-------------------------

   i2.pair i2.cons
1 29.77634 31.8402
[2025-01-08 18:09:47]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-Vascular Toxicity-gen.pdf
[1] "[2025-01-08 18:23:24]############################serious-hypertension-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 71
   Unobserved stochastic nodes: 85
   Total graph size: 1670

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 18:23:24]Saved forest plot: 20250104-gemtc-forest-serious-hypertension-gen.pdf
[2025-01-08 18:23:24]Saved trace/density plot: 20250104-trace_density-serious-hypertension-gen.pdf
[2025-01-08 18:23:24]Saved diagnosis plot: 20250104-gelman.plot-serious-hypertension-gen.pdf
[1] "serious-hypertension-gen[2025-01-08 18:23:24]: gelman.diag"
Potential scale reduction factors:

                       Point est. Upper C.I.
d.I.Chemotherapy             1.06       1.16
d.I.I_chemotherapy           1.00       1.00
d.I.I_IGF_1Ri                   1.02       1.06
d.I.I_METi                   1.01       1.02
d.I.I_antiangio                  1.00       1.00
d.I.II                       1.00       1.00
d.I.III                      1.00       1.00
d.I.Placebo                  1.00       1.00
d.I.antiangio                    1.00       1.00
d.II.II_Cetuximab                 1.01       1.01
d.III.Gef_Erl                1.00       1.00
d.III.III_chemotherapy       1.01       1.01
d.III.III_antiangio              1.00       1.00
sd.d                         1.00       1.00

Multivariate psrf

1.05
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 71
   Unobserved stochastic nodes: 86
   Total graph size: 2134

[1] "serious-hypertension-gen[2025-01-08 18:23:24]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison      p.value  CrI                   
1  d.I.II          0.014575                       
2  -> direct                -0.45 (-2.5, 1.6)     
3  -> indirect              31. (2.1, 97.)        
4  -> network               0.011 (-1.9, 2.3)     
5  d.I.III         0.000275                       
6  -> direct                -32. (-1.1e+02, -1.6) 
7  -> indirect              35. (3.2, 1.1e+02)    
8  -> network               0.46 (-3.9, 4.9)      
9  d.I.Placebo     0.000000                       
10 -> direct                27. (3.0, 69.)        
11 -> indirect              -43. (-90., -10.)     
12 -> network               0.87 (-1.8, 3.8)      
13 d.I_antiangio.antiangio 0.220525                       
14 -> direct                2.9 (-0.17, 6.9)      
15 -> indirect              0.59 (-1.7, 2.9)      
16 -> network               1.5 (-0.34, 3.4)      
17 d.II.Placebo    0.012575                       
18 -> direct                -33. (-1.1e+02, -0.67)
19 -> indirect              2.6 (-1.3, 7.3)       
20 -> network               0.88 (-2.4, 4.0)      
21 d.III.Placebo   0.001150                       
22 -> direct                -27. (-94., -1.1)     
23 -> indirect              33. (2.9, 1.1e+02)    
24 -> network               0.44 (-4.0, 4.8)      
[2025-01-08 18:23:24]Saved diagnosis1 plot: 20250104-Consistency-serious-hypertension-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 71
   Unobserved stochastic nodes: 71
   Total graph size: 1322

[1] "serious-hypertension-gen[2025-01-08 18:23:24]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2  i2.pair  i2.cons   incons.p
1  Chemotherapy                I  0.00000  0.00000         NA
2       Gef_Erl              III       NA       NA         NA
3       I_antiangio            antiangio       NA 45.06982 0.25554231
4             I   I_chemotherapy  0.00000  0.00000         NA
5             I           I_IGF_1Ri       NA       NA         NA
6             I           I_METi       NA       NA         NA
7             I          I_antiangio 58.29126 57.25410         NA
8             I               II 42.53084 53.68350         NA
9             I              III       NA 44.35638 0.12360373
10            I          Placebo  0.00000 39.52086 0.19598292
11            I            antiangio 22.13272 44.69573         NA
12           II          II_Cetuximab       NA       NA         NA
13           II          Placebo       NA 43.80491 0.07410023
14          III III_chemotherapy       NA       NA         NA
15          III        III_antiangio 69.82021 70.85384         NA
16          III          Placebo       NA 44.40858 0.14867877

Global I-squared:
-------------------------

   i2.pair i2.cons
1 69.40626 55.6999
[2025-01-08 18:23:24]Saved diagnosis1 plot: 20250104-Heterogeneity-serious-hypertension-gen.pdf
[1] "[2025-01-08 18:29:28]############################total-arrhythmias-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 110
   Unobserved stochastic nodes: 134
   Total graph size: 2845

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 18:29:28]Saved forest plot: 20250104-gemtc-forest-total-arrhythmias-gen.pdf
[2025-01-08 18:29:28]Saved trace/density plot: 20250104-trace_density-total-arrhythmias-gen.pdf
[2025-01-08 18:29:28]Saved diagnosis plot: 20250104-gelman.plot-total-arrhythmias-gen.pdf
[1] "total-arrhythmias-gen[2025-01-08 18:29:28]: gelman.diag"
Potential scale reduction factors:

                              Point est. Upper C.I.
d.Chemotherapy.I                    1.00       1.00
d.Chemotherapy.I_chemotherapy       1.00       1.00
d.Chemotherapy.II                   1.00       1.00
d.Chemotherapy.III                  1.00       1.00
d.Gef_Erl.Zorifertinib              1.00       1.00
d.I.DHFRi                           1.00       1.00
d.I.I_Autophagyi                    1.00       1.00
d.I.I_HER3i                         1.00       1.00
d.I.I_HGFi                          1.09       1.25
d.I.I_IGF_1Ri                          1.00       1.00
d.I.I_METi                          1.00       1.00
d.I.I_MMPi                          1.00       1.00
d.I.I_antiangio                         1.00       1.00
d.I.Rociletinib                     1.00       1.00
d.I.antiangio                           1.00       1.00
d.II.II_Cetuximab                        1.00       1.00
d.II.II_HMGCRi                      1.00       1.00
d.III.Chemotherapy_antiangio            1.17       1.48
d.III.Gef_Erl                       1.00       1.00
d.III.III_chemotherapy              1.00       1.00
d.III.III_antiangio                     1.00       1.00
d.III.PD_L1i                        1.48       2.55
d.III.Placebo                       1.00       1.00
sd.d                                1.00       1.01

Multivariate psrf

1.41
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 109
   Unobserved stochastic nodes: 134
   Total graph size: 4088

[1] "total-arrhythmias-gen[2025-01-08 18:29:28]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison                    p.value  CrI                   
1  d.Chemotherapy.I              0.493825                       
2  -> direct                              -0.29 (-1.3, 0.51)    
3  -> indirect                            0.33 (-1.3, 2.2)      
4  -> network                             -0.12 (-0.91, 0.56)   
5  d.Chemotherapy.I_chemotherapy 0.886725                       
6  -> direct                              0.18 (-3.9, 4.2)      
7  -> indirect                            0.40 (-1.0, 2.0)      
8  -> network                             0.39 (-0.92, 1.7)     
9  d.Chemotherapy.II             0.038875                       
10 -> direct                              -12. (-1.0e+02, -0.76)
11 -> indirect                            -0.20 (-1.3, 0.76)    
12 -> network                             -0.39 (-1.5, 0.58)    
13 d.Chemotherapy.III            0.177625                       
14 -> direct                              1.0 (-0.52, 3.0)      
15 -> indirect                            -0.22 (-1.4, 0.71)    
16 -> network                             0.10 (-0.76, 0.86)    
17 d.I.II                        0.303950                       
18 -> direct                              -0.098 (-0.92, 0.77)  
19 -> indirect                            -1.2 (-3.0, 0.68)     
20 -> network                             -0.25 (-1.0, 0.48)    
21 d.I.III                       0.346800                       
22 -> direct                              0.12 (-0.47, 0.65)    
23 -> indirect                            0.77 (-0.45, 2.1)     
24 -> network                             0.22 (-0.25, 0.72)    
25 d.I.Placebo                   0.454625                       
26 -> direct                              -2.0 (-6.0, -0.0073)  
27 -> indirect                            -1.0 (-2.0, -0.045)   
28 -> network                             -1.1 (-2.1, -0.33)    
29 d.I_antiangio.antiangio               0.037250                       
30 -> direct                              18. (2.4, 59.)        
31 -> indirect                            2.2 (1.0, 3.6)        
32 -> network                             2.5 (1.4, 3.9)        
33 d.II.Placebo                  0.608625                       
34 -> direct                              -0.53 (-2.8, 1.1)     
35 -> indirect                            -1.1 (-2.5, 0.10)     
36 -> network                             -0.90 (-2.0, 0.10)    
37 d.III.Placebo                 0.963600                       
38 -> direct                              -1.4 (-2.5, -0.39)    
39 -> indirect                            -1.4 (-3.0, -0.00085) 
40 -> network                             -1.4 (-2.3, -0.59)    
[2025-01-08 18:29:28]Saved diagnosis1 plot: 20250104-Consistency-total-arrhythmias-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 110
   Unobserved stochastic nodes: 110
   Total graph size: 2037

[1] "total-arrhythmias-gen[2025-01-08 18:29:28]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

                   t1               t2   i2.pair  i2.cons  incons.p
1  Chemotherapy_antiangio              III        NA       NA        NA
2        Chemotherapy                I  5.115161  0.00000 0.6584429
3        Chemotherapy   I_chemotherapy        NA  0.00000 0.8274636
4        Chemotherapy               II        NA 44.27242 0.5307425
5        Chemotherapy              III        NA 31.85096 0.3119055
6               DHFRi                I        NA       NA        NA
7             Gef_Erl              III        NA       NA        NA
8             Gef_Erl     Zorifertinib        NA       NA        NA
9             I_antiangio            antiangio        NA  0.00000 0.2329163
10                  I     I_Autophagyi        NA       NA        NA
11                  I   I_chemotherapy  0.000000  0.00000        NA
12                  I          I_HER3i        NA       NA        NA
13                  I           I_HGFi        NA       NA        NA
14                  I           I_IGF_1Ri 66.280340 65.57293        NA
15                  I           I_METi  0.000000  0.00000        NA
16                  I           I_MMPi        NA       NA        NA
17                  I          I_antiangio  0.000000  0.00000        NA
18                  I               II 68.289654 63.44851 0.1706382
19                  I              III  0.000000  0.00000 0.6143790
20                  I          Placebo 54.644161 19.55775 0.4835519
21                  I      Rociletinib        NA       NA        NA
22                  I            antiangio 74.399768 78.16127        NA
23                 II          II_Cetuximab        NA       NA        NA
24                 II        II_HMGCRi        NA       NA        NA
25                 II          Placebo  0.000000  0.00000 0.7151604
26                III III_chemotherapy 48.246057 47.49125        NA
27                III        III_antiangio  0.000000  0.00000        NA
28                III           PD_L1i        NA       NA        NA
29                III          Placebo 37.315247  0.00000 0.9374158

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 29.18433 22.65385
[2025-01-08 18:29:28]Saved diagnosis1 plot: 20250104-Heterogeneity-total-arrhythmias-gen.pdf
[1] "[2025-01-08 18:40:52]############################total-heart failure-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 69
   Unobserved stochastic nodes: 85
   Total graph size: 1691

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 18:40:52]Saved forest plot: 20250104-gemtc-forest-total-heart failure-gen.pdf
[2025-01-08 18:40:52]Saved trace/density plot: 20250104-trace_density-total-heart failure-gen.pdf
[2025-01-08 18:40:52]Saved diagnosis plot: 20250104-gelman.plot-total-heart failure-gen.pdf
[1] "total-heart failure-gen[2025-01-08 18:40:52]: gelman.diag"
Potential scale reduction factors:

                       Point est. Upper C.I.
d.I.Chemotherapy             1.00       1.00
d.I.I_chemotherapy           1.00       1.00
d.I.I_HER3i                  1.07       1.20
d.I.I_IGF_1Ri                   1.00       1.00
d.I.I_METi                   1.00       1.00
d.I.I_MMPi                   1.02       1.05
d.I.I_PARPi                  1.02       1.03
d.I.I_antiangio                  1.00       1.00
d.I.II                       1.00       1.00
d.I.III                      1.00       1.00
d.I.Placebo                  1.00       1.00
d.I.antiangio                    1.08       1.16
d.III.Gef_Erl                1.00       1.00
d.III.III_chemotherapy       1.00       1.00
d.III.III_antiangio              1.00       1.00
sd.d                         1.00       1.00

Multivariate psrf

1.08
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 69
   Unobserved stochastic nodes: 86
   Total graph size: 2283

[1] "total-heart failure-gen[2025-01-08 18:40:52]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison         p.value  CrI                
1  d.Chemotherapy.I   0.798775                    
2  -> direct                   0.067 (-4.1, 4.0)  
3  -> indirect                 0.64 (-3.3, 4.9)   
4  -> network                  0.35 (-2.3, 3.0)   
5  d.Chemotherapy.II  0.023100                    
6  -> direct                   -20. (-58., -0.56) 
7  -> indirect                 1.0 (-2.3, 5.6)    
8  -> network                  -0.32 (-3.4, 2.4)  
9  d.Chemotherapy.III 0.015300                    
10 -> direct                   16. (0.49, 57.)    
11 -> indirect                 -2.0 (-6.6, 1.7)   
12 -> network                  0.15 (-2.7, 3.2)   
13 d.I.II             0.357700                    
14 -> direct                   -0.23 (-2.6, 2.1)  
15 -> indirect                 -2.1 (-7.1, 1.3)   
16 -> network                  -0.64 (-2.7, 1.0)  
17 d.I.III            0.885925                    
18 -> direct                   -0.019 (-4.2, 4.3) 
19 -> indirect                 -0.34 (-3.4, 2.9)  
20 -> network                  -0.20 (-2.3, 2.1)  
21 d.I.Placebo        0.018050                    
22 -> direct                   -28. (-68., -2.5)  
23 -> indirect                 -0.59 (-3.4, 1.9)  
24 -> network                  -1.4 (-4.1, 0.44)  
25 d.I_antiangio.antiangio    0.934275                    
26 -> direct                   15. (-0.45, 48.)   
27 -> indirect                 16. (1.0, 60.)     
28 -> network                  15. (1.8, 41.)     
29 d.II.Placebo       0.910875                    
30 -> direct                   -1.1 (-5.1, 2.3)   
31 -> indirect                 -0.87 (-4.8, 2.2)  
32 -> network                  -0.70 (-3.3, 1.3)  
33 d.III.Placebo      0.154125                    
34 -> direct                   -0.75 (-3.4, 1.2)  
35 -> indirect                 -4.2 (-10., -0.033)
36 -> network                  -1.1 (-4.0, 0.24)  
[2025-01-08 18:40:52]Saved diagnosis1 plot: 20250104-Consistency-total-heart failure-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 69
   Unobserved stochastic nodes: 69
   Total graph size: 1280

[1] "total-heart failure-gen[2025-01-08 18:40:52]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2   i2.pair   i2.cons  incons.p
1  Chemotherapy                I 67.963027 35.760652 0.9598126
2  Chemotherapy               II        NA 42.800742 0.4057033
3  Chemotherapy              III        NA 46.211863 0.3606670
4       Gef_Erl              III        NA        NA        NA
5       I_antiangio            antiangio        NA  0.000000 0.5082384
6             I   I_chemotherapy 42.909561 42.013603        NA
7             I          I_HER3i        NA        NA        NA
8             I           I_IGF_1Ri        NA        NA        NA
9             I           I_METi  0.000000  0.000000        NA
10            I           I_MMPi        NA        NA        NA
11            I          I_PARPi        NA        NA        NA
12            I          I_antiangio  6.294509  6.917926        NA
13            I               II  0.000000  0.000000 0.9132360
14            I              III 72.082285 44.628722 0.9536303
15            I          Placebo 95.919901 34.893235 0.5954198
16            I            antiangio  0.000000  0.000000        NA
17           II          Placebo        NA  0.000000 0.9705366
18          III III_chemotherapy        NA        NA        NA
19          III        III_antiangio        NA        NA        NA
20          III          Placebo 56.371318 43.234792 0.9650392

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 91.96322 29.76509
[2025-01-08 18:40:52]Saved diagnosis1 plot: 20250104-Heterogeneity-total-heart failure-gen.pdf
[1] "[2025-01-08 18:47:40]############################total-Vascular Toxicity-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 145
   Unobserved stochastic nodes: 168
   Total graph size: 3484

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 18:47:40]Saved forest plot: 20250104-gemtc-forest-total-Vascular Toxicity-gen.pdf
[2025-01-08 18:47:40]Saved trace/density plot: 20250104-trace_density-total-Vascular Toxicity-gen.pdf
[2025-01-08 18:47:40]Saved diagnosis plot: 20250104-gelman.plot-total-Vascular Toxicity-gen.pdf
[1] "total-Vascular Toxicity-gen[2025-01-08 18:47:40]: gelman.diag"
Potential scale reduction factors:

                       Point est. Upper C.I.
d.Chemotherapy.I             1.00       1.00
d.Chemotherapy.II            1.00       1.00
d.Chemotherapy.III           1.00       1.00
d.I.DHFRi                    1.00       1.00
d.I.I_Autophagyi             1.03       1.07
d.I.I_chemotherapy           1.00       1.00
d.I.I_COX2i                  1.02       1.05
d.I.I_ERi                    1.00       1.00
d.I.I_HER3i                  1.00       1.00
d.I.I_HGFi                   1.00       1.00
d.I.I_IGF_1Ri                   1.00       1.00
d.I.I_METi                   1.00       1.00
d.I.I_MMPi                   1.00       1.00
d.I.I_antiangio                  1.00       1.00
d.I.Placebo                  1.00       1.00
d.I.Rociletinib              1.00       1.00
d.I.antiangio                    1.00       1.00
d.II.II_Cetuximab                 1.00       1.00
d.III.Gef_Erl                1.00       1.00
d.III.III_chemotherapy       1.00       1.00
d.III.III_antiangio              1.00       1.00
d.III.PD_L1i                 1.00       1.00
sd.d                         1.00       1.00

Multivariate psrf

1.02
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 145
   Unobserved stochastic nodes: 169
   Total graph size: 4653

[1] "total-Vascular Toxicity-gen[2025-01-08 18:47:40]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison         p.value  CrI                 
1  d.Chemotherapy.I   0.109950                     
2  -> direct                   -0.28 (-1.1, 0.53)  
3  -> indirect                 -1.6 (-3.1, -0.19)  
4  -> network                  -0.62 (-1.4, 0.11)  
5  d.Chemotherapy.II  0.681975                     
6  -> direct                   -0.78 (-2.8, 1.2)   
7  -> indirect                 -0.32 (-1.5, 0.83)  
8  -> network                  -0.43 (-1.4, 0.52)  
9  d.Chemotherapy.III 0.089475                     
10 -> direct                   -0.36 (-2.1, 1.4)   
11 -> indirect                 1.5 (0.26, 2.7)     
12 -> network                  0.91 (-0.16, 2.0)   
13 d.I.II             0.421075                     
14 -> direct                   -0.022 (-0.96, 0.91)
15 -> indirect                 0.62 (-0.72, 2.0)   
16 -> network                  0.19 (-0.59, 0.94)  
17 d.I.III            0.011800                     
18 -> direct                   2.4 (1.3, 3.6)      
19 -> indirect                 0.20 (-1.1, 1.5)    
20 -> network                  1.5 (0.63, 2.5)     
21 d.I.Placebo        0.890350                     
22 -> direct                   0.040 (-1.0, 1.0)   
23 -> indirect                 -0.073 (-1.4, 1.3)  
24 -> network                  0.0051 (-0.82, 0.79)
25 d.I_antiangio.antiangio    0.386700                     
26 -> direct                   1.5 (-0.84, 4.1)    
27 -> indirect                 0.19 (-1.8, 2.1)    
28 -> network                  0.76 (-0.57, 2.2)   
29 d.II.Placebo       0.193725                     
30 -> direct                   -0.90 (-2.4, 0.51)  
31 -> indirect                 0.32 (-0.89, 1.5)   
32 -> network                  -0.18 (-1.1, 0.76)  
33 d.III.Placebo      0.177800                     
34 -> direct                   -0.59 (-2.4, 1.1)   
35 -> indirect                 -2.1 (-3.5, -0.77)  
36 -> network                  -1.5 (-2.6, -0.47)  
[2025-01-08 18:47:40]Saved diagnosis1 plot: 20250104-Consistency-total-Vascular Toxicity-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 145
   Unobserved stochastic nodes: 145
   Total graph size: 2676

[1] "total-Vascular Toxicity-gen[2025-01-08 18:47:40]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2  i2.pair   i2.cons   incons.p
1  Chemotherapy                I 39.52996 48.307156 0.07098680
2  Chemotherapy               II 54.38552  0.000000 0.71196077
3  Chemotherapy              III       NA 85.371870 0.09491665
4         DHFRi                I       NA        NA         NA
5       Gef_Erl              III       NA        NA         NA
6       I_antiangio            antiangio       NA  0.000000 0.43614480
7             I     I_Autophagyi       NA        NA         NA
8             I   I_chemotherapy 60.58179 61.292397         NA
9             I          I_COX2i       NA        NA         NA
10            I            I_ERi       NA        NA         NA
11            I          I_HER3i       NA        NA         NA
12            I           I_HGFi       NA        NA         NA
13            I           I_IGF_1Ri 67.04836 68.297962         NA
14            I           I_METi  0.00000  0.000000         NA
15            I           I_MMPi       NA        NA         NA
16            I          I_antiangio 33.34343 36.838091         NA
17            I               II 12.71267  5.059998 0.41379154
18            I              III 88.82220 79.763542 0.02962171
19            I          Placebo 30.44392 16.746260 0.85113258
20            I      Rociletinib       NA        NA         NA
21            I            antiangio 47.95767 64.222081         NA
22           II          II_Cetuximab       NA        NA         NA
23           II          Placebo  0.00000 40.978553 0.18417251
24          III III_chemotherapy       NA        NA         NA
25          III        III_antiangio       NA        NA         NA
26          III           PD_L1i       NA        NA         NA
27          III          Placebo  0.00000 27.807797 0.15312106

Global I-squared:
-------------------------

   i2.pair  i2.cons
1 48.66609 48.38386
[2025-01-08 18:47:40]Saved diagnosis1 plot: 20250104-Heterogeneity-total-Vascular Toxicity-gen.pdf
[1] "[2025-01-08 19:01:33]############################total-hypertension-gen######################################"
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 91
   Unobserved stochastic nodes: 107
   Total graph size: 2147

Initializing model

  |++++++++++++++++++++++++++++++++++++++++++++++++++| 100%
  |**************************************************| 100%
[2025-01-08 19:01:33]Saved forest plot: 20250104-gemtc-forest-total-hypertension-gen.pdf
[2025-01-08 19:01:33]Saved trace/density plot: 20250104-trace_density-total-hypertension-gen.pdf
[2025-01-08 19:01:33]Saved diagnosis plot: 20250104-gelman.plot-total-hypertension-gen.pdf
[1] "total-hypertension-gen[2025-01-08 19:01:33]: gelman.diag"
Potential scale reduction factors:

                       Point est. Upper C.I.
d.Chemotherapy.I             1.00       1.00
d.Chemotherapy.II            1.00       1.00
d.Chemotherapy.III           1.00       1.00
d.I.I_Autophagyi             1.00       1.00
d.I.I_chemotherapy           1.00       1.00
d.I.I_IGF_1Ri                   1.00       1.00
d.I.I_METi                   1.13       1.35
d.I.I_antiangio                  1.00       1.00
d.I.Placebo                  1.00       1.00
d.I.antiangio                    1.00       1.00
d.II.II_Cetuximab                 1.00       1.00
d.III.Gef_Erl                1.00       1.00
d.III.III_chemotherapy       1.00       1.00
d.III.III_antiangio              1.00       1.00
d.III.PD_L1i                 1.18       1.48
sd.d                         1.00       1.00

Multivariate psrf

1.15
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 91
   Unobserved stochastic nodes: 108
   Total graph size: 2742

[1] "total-hypertension-gen[2025-01-08 19:01:33]: mtc.nodesplit"
Node-splitting analysis of inconsistency
========================================

   comparison         p.value  CrI                   
1  d.Chemotherapy.I   0.180975                       
2  -> direct                   -2.4 (-6.0, -0.29)    
3  -> indirect                 -0.70 (-1.9, 0.53)    
4  -> network                  -1.1 (-2.2, -0.092)   
5  d.Chemotherapy.II  0.316925                       
6  -> direct                   -0.80 (-2.2, 0.58)    
7  -> indirect                 -1.9 (-3.7, -0.20)    
8  -> network                  -1.2 (-2.3, -0.16)    
9  d.Chemotherapy.III 0.840700                       
10 -> direct                   -0.87 (-2.4, 0.59)    
11 -> indirect                 -1.1 (-2.8, 0.47)     
12 -> network                  -0.94 (-2.1, 0.091)   
13 d.I.II             0.178675                       
14 -> direct                   -0.52 (-1.8, 0.59)    
15 -> indirect                 0.90 (-0.84, 2.9)     
16 -> network                  -0.11 (-1.1, 0.85)    
17 d.I.III            0.498575                       
18 -> direct                   -0.021 (-1.0, 0.99)   
19 -> indirect                 0.67 (-1.1, 2.7)      
20 -> network                  0.12 (-0.71, 1.0)     
21 d.I.Placebo        0.013200                       
22 -> direct                   0.41 (-0.77, 1.7)     
23 -> indirect                 -19. (-81., -1.1)     
24 -> network                  0.11 (-1.1, 1.2)      
25 d.I_antiangio.antiangio    0.716175                       
26 -> direct                   0.16 (-1.3, 1.6)      
27 -> indirect                 0.49 (-0.69, 1.7)     
28 -> network                  0.36 (-0.49, 1.2)     
29 d.II.Placebo       0.029325                       
30 -> direct                   -34. (-1.4e+02, -0.68)
31 -> indirect                 0.42 (-1.1, 1.9)      
32 -> network                  0.22 (-1.2, 1.6)      
33 d.III.Placebo      0.023900                       
34 -> direct                   -29. (-81., -1.3)     
35 -> indirect                 0.23 (-1.2, 1.7)      
36 -> network                  -0.013 (-1.4, 1.3)    
[2025-01-08 19:01:33]Saved diagnosis1 plot: 20250104-Consistency-total-hypertension-gen.pdf
Compiling model graph
   Resolving undeclared variables
   Allocating nodes
Graph information:
   Observed stochastic nodes: 91
   Unobserved stochastic nodes: 91
   Total graph size: 1706

[1] "total-hypertension-gen[2025-01-08 19:01:33]: mtc.anohe"
Analysis of heterogeneity
=========================

Per-comparison I-squared:
-------------------------

             t1               t2  i2.pair  i2.cons  incons.p
1  Chemotherapy                I 41.59390 22.65604 0.2932416
2  Chemotherapy               II       NA 16.51943 0.4552785
3  Chemotherapy              III       NA  0.00000 0.8999682
4       Gef_Erl              III       NA       NA        NA
5       I_antiangio            antiangio       NA  0.00000 0.7480254
6             I     I_Autophagyi       NA       NA        NA
7             I   I_chemotherapy  0.00000  0.00000        NA
8             I           I_IGF_1Ri       NA       NA        NA
9             I           I_METi       NA       NA        NA
10            I          I_antiangio 71.76535 71.63459        NA
11            I               II 54.54841 29.12236 0.3262178
12            I              III  0.00000  0.00000 0.6485369
13            I          Placebo 45.27379 16.29796 0.3553650
14            I            antiangio  0.00000  0.00000        NA
15           II          II_Cetuximab       NA       NA        NA
16           II          Placebo       NA 42.58754 0.2490086
17          III III_chemotherapy 45.97135 44.56761        NA
18          III        III_antiangio 39.52156 38.96013        NA
19          III           PD_L1i       NA       NA        NA
20          III          Placebo       NA 42.55755 0.3603152

Global I-squared:
-------------------------

   i2.pair i2.cons
1 58.11537 53.1949
[2025-01-08 19:01:33]Saved diagnosis1 plot: 20250104-Heterogeneity-total-hypertension-gen.pdf